BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, Sordillo EM, Fowkes M. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol 2020;92:699-702. [PMID: 32314810 DOI: 10.1002/jmv.25915] [Cited by in Crossref: 365] [Cited by in F6Publishing: 350] [Article Influence: 182.5] [Reference Citation Analysis]
Number Citing Articles
1 Saha M, Amin SB, Sharma A, Kumar TKS, Kalia RK. AI-DRIVEN QUANTIFICATION OF GROUND GLASS OPACITIES IN LUNGS OF COVID-19 PATIENTS USING 3D COMPUTED TOMOGRAPHY IMAGING. medRxiv 2021:2021. [PMID: 34268519 DOI: 10.1101/2021.07.06.21260109] [Reference Citation Analysis]
2 Reza-Zaldívar EE, Hernández-Sapiéns MA, Minjarez B, Gómez-Pinedo U, Márquez-Aguirre AL, Mateos-Díaz JC, Matias-Guiu J, Canales-Aguirre AA. Infection Mechanism of SARS-COV-2 and Its Implication on the Nervous System. Front Immunol 2020;11:621735. [PMID: 33584720 DOI: 10.3389/fimmu.2020.621735] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
3 Korsukewitz C, Reddel SW, Bar-Or A, Wiendl H. Neurological immunotherapy in the era of COVID-19 - looking for consensus in the literature. Nat Rev Neurol 2020;16:493-505. [PMID: 32641860 DOI: 10.1038/s41582-020-0385-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 13.0] [Reference Citation Analysis]
4 Kalra RS, Dhanjal JK, Meena AS, Kalel VC, Dahiya S, Singh B, Dewanjee S, Kandimalla R. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications. Front Aging Neurosci 2021;13:662786. [PMID: 34149397 DOI: 10.3389/fnagi.2021.662786] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Edlow BL, Boly M, Chou SH, Fischer D, Kondziella D, Li LM, Mac Donald CL, McNett M, Newcombe VFJ, Stevens RD, Menon DK; GCS-NeuroCOVID. Common Data Elements for COVID-19 Neuroimaging: A GCS-NeuroCOVID Proposal. Neurocrit Care 2021;34:365-70. [PMID: 33575956 DOI: 10.1007/s12028-021-01192-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Al-Dalahmah O, Thakur KT, Nordvig AS, Prust ML, Roth W, Lignelli A, Uhlemann AC, Miller EH, Kunnath-Velayudhan S, Del Portillo A, Liu Y, Hargus G, Teich AF, Hickman RA, Tanji K, Goldman JE, Faust PL, Canoll P. Neuronophagia and microglial nodules in a SARS-CoV-2 patient with cerebellar hemorrhage. Acta Neuropathol Commun 2020;8:147. [PMID: 32847628 DOI: 10.1186/s40478-020-01024-2] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 17.5] [Reference Citation Analysis]
7 Keyhanian K, Umeton RP, Mohit B, Davoudi V, Hajighasemi F, Ghasemi M. SARS-CoV-2 and nervous system: From pathogenesis to clinical manifestation. J Neuroimmunol 2020;350:577436. [PMID: 33212316 DOI: 10.1016/j.jneuroim.2020.577436] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
8 Trejo-Gabriel-Galán JM. Stroke as a complication and prognostic factor of COVID-19. Neurologia (Engl Ed) 2020;35:318-22. [PMID: 32493597 DOI: 10.1016/j.nrl.2020.04.015] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
9 Timmons GM, Rempe T, Bevins EA, Goodwill V, Miner A, Kavanaugh A, Ritter M, Graves JS. CNS Lymphocytic Vasculitis in a Young Woman With COVID-19 Infection. Neurol Neuroimmunol Neuroinflamm 2021;8:e1048. [PMID: 34321332 DOI: 10.1212/NXI.0000000000001048] [Reference Citation Analysis]
10 Glinsky GV. Tripartite Combination of Candidate Pandemic Mitigation Agents: Vitamin D, Quercetin, and Estradiol Manifest Properties of Medicinal Agents for Targeted Mitigation of the COVID-19 Pandemic Defined by Genomics-Guided Tracing of SARS-CoV-2 Targets in Human Cells. Biomedicines 2020;8:E129. [PMID: 32455629 DOI: 10.3390/biomedicines8050129] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 26.0] [Reference Citation Analysis]
11 Ghannoum MA, Ford M, Bonomo RA, Gamal A, McCormick TS. A Microbiome-Driven Approach to Combating Depression During the COVID-19 Pandemic. Front Nutr 2021;8:672390. [PMID: 34504858 DOI: 10.3389/fnut.2021.672390] [Reference Citation Analysis]
12 von Weyhern CH, Kaufmann I, Neff F, Kremer M. Early evidence of pronounced brain involvement in fatal COVID-19 outcomes. Lancet 2020;395:e109. [PMID: 32505222 DOI: 10.1016/S0140-6736(20)31282-4] [Cited by in Crossref: 127] [Cited by in F6Publishing: 77] [Article Influence: 63.5] [Reference Citation Analysis]
13 Cárdenas G, Chávez-canales M, Espinosa AM, Jordán-ríos A, Malagon DA, Murillo MFM, Araujo LVT, Campos RLB, Wong-chew RM, González LER, Cresencio KI, Velázquez EG, de la Cerda MR, Leyva Y, Hernández-ruiz J, Hernández-medel ML, León-hernández M, Quero KM, Monciváis AS, Díaz SH, Martínez IRZ, Martínez-cuazitl A, Salazar INM, Sarmiento EB, Peña AF, Hernández PS, Reynoso RIA, Reyes DM, del Río Ambriz LR, Bonilla RAA, Cruz J, Huerta L, Fierro NA, Hernández M, Pérez-tapia M, Meneses G, Espíndola-arriaga E, Rosas G, Chinney A, Mendoza SR, Hernández-aceves JA, Cervantes-torres J, Rodríguez AF, Alor RO, Francisco SO, Salazar EA, Besedovsky H, Romano MC, Bobes RJ, Jung H, Soldevila G, López-alvarenga J, Fragoso G, Laclette JP, Sciutto E. Intranasal dexamethasone: a new clinical trial for the control of inflammation and neuroinflammation in COVID-19 patients. Trials 2022;23. [DOI: 10.1186/s13063-022-06075-5] [Reference Citation Analysis]
14 Karn V, Ahmed S, Tsai LW, Dubey R, Ojha S, Singh HN, Kumar M, Gupta PK, Sadhu S, Jha NK, Kumar A, Pandit S, Kumar S. Extracellular Vesicle-Based Therapy for COVID-19: Promises, Challenges and Future Prospects. Biomedicines 2021;9:1373. [PMID: 34680490 DOI: 10.3390/biomedicines9101373] [Reference Citation Analysis]
15 Pittams A, Axiaq A, Qamar A, Botezatu B, Harky A. The Correlation Between Stroke and Coronavirus Disease (COVID-19): Where is the Evidence? EMJ. [DOI: 10.33590/emj/20-00184] [Reference Citation Analysis]
16 Sessa F, Salerno M, Pomara C. Autopsy Tool in Unknown Diseases: The Experience with Coronaviruses (SARS-CoV, MERS-CoV, SARS-CoV-2). Medicina (Kaunas) 2021;57:309. [PMID: 33806100 DOI: 10.3390/medicina57040309] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
17 Villa C, Rivellini E, Lavitrano M, Combi R. Can SARS-CoV-2 Infection Exacerbate Alzheimer's Disease? An Overview of Shared Risk Factors and Pathogenetic Mechanisms. J Pers Med 2022;12:29. [PMID: 35055344 DOI: 10.3390/jpm12010029] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
18 El-Zein RS, Cardinali S, Murphy C, Keeling T. COVID-19-associated meningoencephalitis treated with intravenous immunoglobulin. BMJ Case Rep 2020;13:e237364. [PMID: 32895254 DOI: 10.1136/bcr-2020-237364] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
19 Katti V, Ramamurthy LB, Kanakpur S, Shet SD, Dhoot M. Neuro-ophthalmic presentation of COVID-19 disease: A case report. Indian J Ophthalmol 2021;69:992-4. [PMID: 33727476 DOI: 10.4103/ijo.IJO_3321_20] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
20 Puoti MG, Rybak A, Kiparissi F, Gaynor E, Borrelli O. SARS-CoV-2 and the Gastrointestinal Tract in Children. Front Pediatr 2021;9:617980. [PMID: 33692973 DOI: 10.3389/fped.2021.617980] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
21 Pinninti SG, Pati S, Poole C, Latting M, Seleme MC, Yarbrough A, Arora N, Britt WJ, Boppana S. Virological Characteristics of Hospitalized Children With SARS-CoV-2 Infection. Pediatrics 2021;147:e2020037812. [PMID: 33622794 DOI: 10.1542/peds.2020-037812] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Bostancıklıoğlu M. SARS-CoV2 entry and spread in the lymphatic drainage system of the brain. Brain Behav Immun 2020;87:122-3. [PMID: 32360606 DOI: 10.1016/j.bbi.2020.04.080] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 12.0] [Reference Citation Analysis]
23 Maury A, Lyoubi A, Peiffer-Smadja N, de Broucker T, Meppiel E. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians. Rev Neurol (Paris) 2021;177:51-64. [PMID: 33446327 DOI: 10.1016/j.neurol.2020.10.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
24 Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 targets SARS-CoV-2 co-factor Neuropilin-1 in human brain microvascular endothelial cells: Insights for COVID-19 neurological manifestations. Res Sq 2021:rs. [PMID: 33564755 DOI: 10.21203/rs.3.rs-192099/v1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
25 Mahalaxmi I, Kaavya J, Mohana Devi S, Balachandar V. COVID-19 and olfactory dysfunction: A possible associative approach towards neurodegenerative diseases. J Cell Physiol 2021;236:763-70. [PMID: 32697344 DOI: 10.1002/jcp.29937] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
26 Veenhuis RT, Zeiss CJ. Animal Models of COVID-19 II. Comparative Immunology. ILAR J 2021:ilab010. [PMID: 33914873 DOI: 10.1093/ilar/ilab010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
27 Porta-Etessam J, Núñez-Gil IJ, González García N, Fernandez-Perez C, Viana-Llamas MC, Eid CM, Romero R, Molina M, Uribarri A, Becerra-Muñoz VM, Aguado MG, Huang J, Rondano E, Cerrato E, Alfonso E, Mejía AFC, Marin F, Roubin SR, Pepe M, Feltes G, Maté P, Cortese B, Buzón L, Mendez JJ, Estrada V. COVID-19 anosmia and gustatory symptoms as a prognosis factor: a subanalysis of the HOPE COVID-19 (Health Outcome Predictive Evaluation for COVID-19) registry. Infection 2021;49:677-84. [PMID: 33646505 DOI: 10.1007/s15010-021-01587-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Shakaryan AK, Pylaeva SK, Perekopskaya NE, Sayfullin RF, Belyakova AV. [Guillain-Barre syndrome with cranial nerve damage as complication of COVID-19]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:100-3. [PMID: 34693696 DOI: 10.17116/jnevro2021121091100] [Reference Citation Analysis]
29 Dolatshahi M, Sabahi M, Aarabi MH. Pathophysiological Clues to How the Emergent SARS-CoV-2 Can Potentially Increase the Susceptibility to Neurodegeneration. Mol Neurobiol 2021;58:2379-94. [PMID: 33417221 DOI: 10.1007/s12035-020-02236-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
30 Jeevanandam J, Banerjee S, Paul R. Challenges and Opportunities to Develop Diagnostics and Therapeutic Interventions for Severe Acute Respiratory Syndrome- Corona Virus 2 (SARS-COV-2). J Biomed Res Environ Sci 2020;6:219-32. [DOI: 10.37871/jbres1147] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
31 Sweet AN, André NM, Stout AE, Licitra BN, Whittaker GR. Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP). Viruses 2022;14:481. [DOI: 10.3390/v14030481] [Reference Citation Analysis]
32 Trottein F, Sokol H. Potential Causes and Consequences of Gastrointestinal Disorders during a SARS-CoV-2 Infection. Cell Rep 2020;32:107915. [PMID: 32649864 DOI: 10.1016/j.celrep.2020.107915] [Cited by in Crossref: 55] [Cited by in F6Publishing: 39] [Article Influence: 27.5] [Reference Citation Analysis]
33 Ribeiro DE, Oliveira-Giacomelli Á, Glaser T, Arnaud-Sampaio VF, Andrejew R, Dieckmann L, Baranova J, Lameu C, Ratajczak MZ, Ulrich H. Hyperactivation of P2X7 receptors as a culprit of COVID-19 neuropathology. Mol Psychiatry 2021;26:1044-59. [PMID: 33328588 DOI: 10.1038/s41380-020-00965-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
34 Morowitz JM, Pogson KB, Roque DA, Church FC. Role of SARS-CoV-2 in Modifying Neurodegenerative Processes in Parkinson’s Disease: A Narrative Review. Brain Sciences 2022;12:536. [DOI: 10.3390/brainsci12050536] [Reference Citation Analysis]
35 Affes Z, Bouvard E, Levy P, Dussaule C, Grateau G, Haymann J. COVID-19 Presenting With Confusion: An Unusual but Suggestive Electroencephalography Pattern of Encephalitis. Journal of Clinical Neurophysiology 2021;38:e11-3. [DOI: 10.1097/wnp.0000000000000795] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
36 [DOI: 10.1101/2020.06.08.139329] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
37 Reddy ST, Garg T, Shah C, Nascimento FA, Imran R, Kan P, Bowry R, Gonzales N, Barreto A, Kumar A, Volpi J, Misra V, Chiu D, Gadhia R, Savitz SI. Cerebrovascular Disease in Patients with COVID-19: A Review of the Literature and Case Series. Case Rep Neurol 2020;12:199-209. [PMID: 32647526 DOI: 10.1159/000508958] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 21.5] [Reference Citation Analysis]
38 Eliseeva DD, Vasiliev AV, Abramova AA, Kochergin IA, Zakharova MN. [Monoclonal antibody therapies for rapidly progressive and highly active multiple sclerosis in the era of the COVID-19 pandemic]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:31-6. [PMID: 34387443 DOI: 10.17116/jnevro202112107231] [Reference Citation Analysis]
39 McManus RM. The Role of Immunity in Alzheimer's Disease. Adv Biol (Weinh) 2022;:e2101166. [PMID: 35254006 DOI: 10.1002/adbi.202101166] [Reference Citation Analysis]
40 Giani AM, Chen S. Human pluripotent stem cell-based organoids and cell platforms for modelling SARS-CoV-2 infection and drug discovery. Stem Cell Res 2021;53:102207. [PMID: 33677394 DOI: 10.1016/j.scr.2021.102207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
41 Ghannam M, Alshaer Q, Al-Chalabi M, Zakarna L, Robertson J, Manousakis G. Neurological involvement of coronavirus disease 2019: a systematic review. J Neurol 2020;267:3135-53. [PMID: 32561990 DOI: 10.1007/s00415-020-09990-2] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 18.0] [Reference Citation Analysis]
42 Vargas-Gandica J, Winter D, Schnippe R, Rodriguez-Morales AG, Mondragon J, Escalera-Antezana JP, Trelles-Thorne MDP, Bonilla-Aldana DK, Rodriguez-Morales AJ, Paniz-Mondolfi A. Ageusia and anosmia, a common sign of COVID-19? A case series from four countries. J Neurovirol 2020;26:785-9. [PMID: 32666422 DOI: 10.1007/s13365-020-00875-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
43 Bourmistrova NW, Solomon T, Braude P, Strawbridge R, Carter B. Long-term effects of COVID-19 on mental health: A systematic review. J Affect Disord 2021;299:118-25. [PMID: 34798148 DOI: 10.1016/j.jad.2021.11.031] [Reference Citation Analysis]
44 Sepehrinezhad A, Gorji A, Sahab Negah S. SARS-CoV-2 may trigger inflammasome and pyroptosis in the central nervous system: a mechanistic view of neurotropism. Inflammopharmacology 2021;29:1049-59. [PMID: 34241783 DOI: 10.1007/s10787-021-00845-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Fortini F, Vieceli Dalla Sega F, Marracino L, Severi P, Rapezzi C, Rizzo P, Ferrari R. Well-Known and Novel Players in Endothelial Dysfunction: Updates on a Notch(ed) Landscape. Biomedicines 2021;9:997. [PMID: 34440201 DOI: 10.3390/biomedicines9080997] [Reference Citation Analysis]
46 Cárdenas G, Torres-García D, Cervantes-Torres J, Rosales-Mendoza S, Fleury A, Fragoso G, Laclette JP, Sciutto E. Role of Systemic and Nasal Glucocorticoid Treatment in the Regulation of the Inflammatory Response in Patients with SARS-Cov-2 Infection. Arch Med Res 2021;52:143-50. [PMID: 33160751 DOI: 10.1016/j.arcmed.2020.10.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
47 Joag V, Wijeyesinghe S, Stolley JM, Quarnstrom CF, Dileepan T, Soerens AG, Sangala JA, O'Flanagan SD, Gavil NV, Hong SW, Bhela S, Gangadhara S, Weyu E, Matchett WE, Thiede J, Krishna V, Cheeran MC, Bold TD, Amara R, Southern P, Hart GT, Schifanella L, Vezys V, Jenkins MK, Langlois RA, Masopust D. Cutting Edge: Mouse SARS-CoV-2 Epitope Reveals Infection and Vaccine-Elicited CD8 T Cell Responses. J Immunol 2021;206:931-5. [PMID: 33441437 DOI: 10.4049/jimmunol.2001400] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
48 Boehme AK, Doyle K, Thakur KT, Roh D, Park S, Agarwal S, Velazquez AG, Egbebike JA, Der Nigoghossian C, Prust ML, Rosenberg J, Brodie D, Fishkoff KN, Hochmann BR, Rabani LE, Yip NH, Panzer O, Claassen J. Disorders of Consciousness in Hospitalized Patients with COVID-19: The Role of the Systemic Inflammatory Response Syndrome. Neurocrit Care 2021. [PMID: 34184176 DOI: 10.1007/s12028-021-01256-7] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
49 Bouali-Benazzouz R, Benazzouz A. Covid-19 Infection and Parkinsonism: Is There a Link? Mov Disord 2021;36:1737-43. [PMID: 34080714 DOI: 10.1002/mds.28680] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Elfasi A, Echevarria FD, Rodriguez R, Roman Casul YA, Khanna AY, Mankowski RT, Simpkins AN. Impact of COVID-19 on Future Ischemic Stroke Incidence. eNeurologicalSci 2021;22:100325. [PMID: 33553699 DOI: 10.1016/j.ensci.2021.100325] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Ziuzia-januszewska L, Januszewski M. Pathogenesis of Olfactory Disorders in COVID-19. Brain Sciences 2022;12:449. [DOI: 10.3390/brainsci12040449] [Reference Citation Analysis]
52 Barbosa LC, Gonçalves TL, de Araujo LP, Rosario LVO, Ferrer VP. Endothelial cells and SARS-CoV-2: An intimate relationship. Vascul Pharmacol 2021;137:106829. [PMID: 33422689 DOI: 10.1016/j.vph.2021.106829] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
53 Bohmwald K, Andrade CA, Gálvez NMS, Mora VP, Muñoz JT, Kalergis AM. The Causes and Long-Term Consequences of Viral Encephalitis. Front Cell Neurosci 2021;15:755875. [DOI: 10.3389/fncel.2021.755875] [Reference Citation Analysis]
54 Chen S, Lu H, Liu Z, Yuan W. Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)". J Med Virol 2020;92:1399-400. [PMID: 32383264 DOI: 10.1002/jmv.25991] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
55 [DOI: 10.1101/2020.07.15.20154260] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Dong M, Zhang J, Ma X, Tan J, Chen L, Liu S, Xin Y, Zhuang L. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother 2020;131:110678. [PMID: 32861070 DOI: 10.1016/j.biopha.2020.110678] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 19.5] [Reference Citation Analysis]
57 Bakhtazad A, Garmabi B, Joghataei MT. Neurological manifestations of coronavirus infections, before and after COVID-19: a review of animal studies. J Neurovirol 2021. [PMID: 34727365 DOI: 10.1007/s13365-021-01014-7] [Reference Citation Analysis]
58 Samimi N, Farjam M, Klionsky DJ, Rezaei N. The role of autophagy in the pathogenesis of SARS-CoV-2 infection in different cell types. Autophagy 2021;:1-4. [PMID: 34709967 DOI: 10.1080/15548627.2021.1989150] [Reference Citation Analysis]
59 Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy. Atherosclerosis 2021;322:39-50. [PMID: 33706082 DOI: 10.1016/j.atherosclerosis.2021.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
60 Sun M, Ruan X, Li Y, Wang P, Zheng S, Shui G, Li L, Huang Y, Zhang H. Clinical characteristics of 30 COVID-19 patients with epilepsy: A retrospective study in Wuhan. Int J Infect Dis 2021;103:647-53. [PMID: 33017697 DOI: 10.1016/j.ijid.2020.09.1475] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
61 Almqvist J, Granberg T, Tzortzakakis A, Klironomos S, Kollia E, Öhberg C, Martin R, Piehl F, Ouellette R, Ineichen BV. Neurological manifestations of coronavirus infections - a systematic review. Ann Clin Transl Neurol 2020;7:2057-71. [PMID: 32853453 DOI: 10.1002/acn3.51166] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 15.5] [Reference Citation Analysis]
62 Martynov MY, Bogolepova AN, Yasamanova AN. [Endothelial dysfunction in COVID- 19 and cognitive impairment]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:93-9. [PMID: 34283537 DOI: 10.17116/jnevro202112106193] [Reference Citation Analysis]
63 Tony AA, Ahmed SBA, Tony EAE, Maklad S, Elnakeeb I, Amin MM. Predictors of Neurological Presentations of COVID-19 Infected Patients in South Egypt, Aswan Governorate: A Single Center Study. Neuropsychiatr Dis Treat 2021;17:3471-82. [PMID: 34880616 DOI: 10.2147/NDT.S333109] [Reference Citation Analysis]
64 Pirraglia MP, Ceccarelli G, Cerini A, Visioli G, d'Ettorre G, Mastroianni CM, Pugliese F, Lambiase A, Gharbiya M. Retinal involvement and ocular findings in COVID-19 pneumonia patients. Sci Rep 2020;10:17419. [PMID: 33060700 DOI: 10.1038/s41598-020-74446-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 9.5] [Reference Citation Analysis]
65 Bodnar B, Patel K, Ho W, Luo JJ, Hu W. Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19. J Med Virol 2021;93:1983-98. [PMID: 33300152 DOI: 10.1002/jmv.26720] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
66 Norouzi M, Miar P, Norouzi S, Nikpour P. Nervous System Involvement in COVID-19: a Review of the Current Knowledge. Mol Neurobiol 2021;58:3561-74. [PMID: 33765290 DOI: 10.1007/s12035-021-02347-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
67 Toniolo S, Di Lorenzo F, Scarioni M, Frederiksen KS, Nobili F. Is the Frontal Lobe the Primary Target of SARS-CoV-2? J Alzheimers Dis 2021;81:75-81. [PMID: 33720900 DOI: 10.3233/JAD-210008] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
68 Limanaqi F, Busceti CL, Biagioni F, Lazzeri G, Forte M, Schiavon S, Sciarretta S, Frati G, Fornai F. Cell Clearing Systems as Targets of Polyphenols in Viral Infections: Potential Implications for COVID-19 Pathogenesis.Antioxidants (Basel). 2020;9:1105. [PMID: 33182802 DOI: 10.3390/antiox9111105] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
69 Kozian R, Chaaban A. [Mania after COVID-19 Infection]. Psychiatr Prax 2022;49:51-3. [PMID: 34979577 DOI: 10.1055/a-1642-7701] [Reference Citation Analysis]
70 Wielgat P, Narejko K, Car H. SARS-CoV-2 Attacks in the Brain: Focus on the Sialome. Cells 2022;11:1458. [DOI: 10.3390/cells11091458] [Reference Citation Analysis]
71 Gavriilaki E, Eftychidis I, Papassotiriou I. Update on endothelial dysfunction in COVID-19: severe disease, long COVID-19 and pediatric characteristics. Journal of Laboratory Medicine 2021;45:293-302. [DOI: 10.1515/labmed-2021-0134] [Reference Citation Analysis]
72 Sandoval F, Julio K, Méndez G, Valderas C, Echeverría AC, Perinetti MJ, Suarez NM, Barraza G, Piñera C, Alarcón M, Samaniego F, Quesada-Rios P, Robles C, Izquierdo G. Neurologic Features Associated With SARS-CoV-2 Infection in Children: A Case Series Report. J Child Neurol 2021;:883073821989164. [PMID: 33646895 DOI: 10.1177/0883073821989164] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
73 El-Sayed A, Aleya L, Kamel M. COVID-19: a new emerging respiratory disease from the neurological perspective. Environ Sci Pollut Res Int 2021;28:40445-59. [PMID: 33590398 DOI: 10.1007/s11356-021-12969-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
74 Meinhardt J, Radke J, Dittmayer C, Franz J, Thomas C, Mothes R, Laue M, Schneider J, Brünink S, Greuel S, Lehmann M, Hassan O, Aschman T, Schumann E, Chua RL, Conrad C, Eils R, Stenzel W, Windgassen M, Rößler L, Goebel HH, Gelderblom HR, Martin H, Nitsche A, Schulz-Schaeffer WJ, Hakroush S, Winkler MS, Tampe B, Scheibe F, Körtvélyessy P, Reinhold D, Siegmund B, Kühl AA, Elezkurtaj S, Horst D, Oesterhelweg L, Tsokos M, Ingold-Heppner B, Stadelmann C, Drosten C, Corman VM, Radbruch H, Heppner FL. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat Neurosci 2021;24:168-75. [PMID: 33257876 DOI: 10.1038/s41593-020-00758-5] [Cited by in Crossref: 168] [Cited by in F6Publishing: 199] [Article Influence: 84.0] [Reference Citation Analysis]
75 Simões JLB, Bagatini MD. Purinergic Signaling of ATP in COVID-19 Associated Guillain-Barré Syndrome. J Neuroimmune Pharmacol 2021;16:48-58. [PMID: 33462776 DOI: 10.1007/s11481-020-09980-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
76 Valderas C, Méndez G, Echeverría A, Suarez N, Julio K, Sandoval F. COVID-19 and neurologic manifestations: a synthesis from the child neurologist's corner. World J Pediatr 2022. [PMID: 35476245 DOI: 10.1007/s12519-022-00550-4] [Reference Citation Analysis]
77 Frontera JA, Sabadia S, Lalchan R, Fang T, Flusty B, Millar-Vernetti P, Snyder T, Berger S, Yang D, Granger A, Morgan N, Patel P, Gutman J, Melmed K, Agarwal S, Bokhari M, Andino A, Valdes E, Omari M, Kvernland A, Lillemoe K, Chou SH, McNett M, Helbok R, Mainali S, Fink EL, Robertson C, Schober M, Suarez JI, Ziai W, Menon D, Friedman D, Friedman D, Holmes M, Huang J, Thawani S, Howard J, Abou-Fayssal N, Krieger P, Lewis A, Lord AS, Zhou T, Kahn DE, Czeisler BM, Torres J, Yaghi S, Ishida K, Scher E, de Havenon A, Placantonakis D, Liu M, Wisniewski T, Troxel AB, Balcer L, Galetta S. A Prospective Study of Neurologic Disorders in Hospitalized Patients With COVID-19 in New York City. Neurology 2021;96:e575-86. [PMID: 33020166 DOI: 10.1212/WNL.0000000000010979] [Cited by in Crossref: 66] [Cited by in F6Publishing: 36] [Article Influence: 33.0] [Reference Citation Analysis]
78 Mone P, Gambardella J, Wang X, Jankauskas SS, Matarese A, Santulli G. miR-24 Targets the Transmembrane Glycoprotein Neuropilin-1 in Human Brain Microvascular Endothelial Cells. Noncoding RNA 2021;7:9. [PMID: 33540664 DOI: 10.3390/ncrna7010009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
79 Engin AB, Engin ED, Engin A. Current opinion in neurological manifestations of SARS-CoV-2 infection. Curr Opin Toxicol 2021;25:49-56. [PMID: 33817451 DOI: 10.1016/j.cotox.2021.03.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
80 Jin YY, Lin H, Cao L, Wu WC, Ji Y, Du L, Jiang Y, Xie Y, Tong K, Xing F, Zheng F, Shi M, Pan JA, Peng X, Guo D. A Convenient and Biosafe Replicon with Accessory Genes of SARS-CoV-2 and Its Potential Application in Antiviral Drug Discovery. Virol Sin 2021. [PMID: 33999369 DOI: 10.1007/s12250-021-00385-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Zhang R, Sun C, Chen X, Han Y, Zang W, Jiang C, Wang J, Wang J. COVID-19-Related Brain Injury: The Potential Role of Ferroptosis. JIR 2022;Volume 15:2181-98. [DOI: 10.2147/jir.s353467] [Reference Citation Analysis]
82 Gomes I, Karmirian K, Oliveira JT, Pedrosa CDSG, Mendes MA, Rosman FC, Chimelli L, Rehen S. SARS-CoV-2 infection of the central nervous system in a 14-month-old child: A case report of a complete autopsy. Lancet Reg Health Am 2021;2:100046. [PMID: 34485969 DOI: 10.1016/j.lana.2021.100046] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
83 Ellul MA, Benjamin L, Singh B, Lant S, Michael BD, Easton A, Kneen R, Defres S, Sejvar J, Solomon T. Neurological associations of COVID-19. Lancet Neurol. 2020;19:767-783. [PMID: 32622375 DOI: 10.1016/s1474-4422(20)30221-0] [Cited by in Crossref: 627] [Cited by in F6Publishing: 384] [Article Influence: 313.5] [Reference Citation Analysis]
84 Govil-Dalela T, Sivaswamy L. Neurological Effects of COVID-19 in Children. Pediatr Clin North Am 2021;68:1081-91. [PMID: 34538300 DOI: 10.1016/j.pcl.2021.05.010] [Reference Citation Analysis]
85 Amanat M, Rezaei N, Roozbeh M, Shojaei M, Tafakhori A, Zoghi A, Darazam IA, Salehi M, Karimialavijeh E, Lima BS, Garakani A, Vaccaro A, Ramezani M. Neurological manifestations as the predictors of severity and mortality in hospitalized individuals with COVID-19: a multicenter prospective clinical study. BMC Neurol 2021;21:116. [PMID: 33726699 DOI: 10.1186/s12883-021-02152-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
86 Nagu P, Parashar A, Behl T, Mehta V. CNS implications of COVID-19: a comprehensive review. Rev Neurosci 2021;32:219-34. [PMID: 33550782 DOI: 10.1515/revneuro-2020-0070] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
87 Bhaskar S, Sinha A, Banach M, Mittoo S, Weissert R, Kass JS, Rajagopal S, Pai AR, Kutty S. Cytokine Storm in COVID-19-Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper. Front Immunol. 2020;11:1648. [PMID: 32754159 DOI: 10.3389/fimmu.2020.01648] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 56.0] [Reference Citation Analysis]
88 Franca RA, Ugga L, Guadagno E, Russo D, Del Basso De Caro M. Neuroinvasive potential of SARS-CoV2 with neuroradiological and neuropathological findings: is the brain a target or a victim? APMIS 2021;129:37-54. [PMID: 33098147 DOI: 10.1111/apm.13092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
89 Unnithan AKA. A brief review of the neurological manifestations of the coronavirus disease. Egypt J Neurol Psychiatr Neurosurg 2020;56:109. [PMID: 33250631 DOI: 10.1186/s41983-020-00244-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
90 Krasemann S, Glatzel M, Pless O. Response to: SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe. Stem Cell Reports 2022;17:1014-5. [PMID: 35545023 DOI: 10.1016/j.stemcr.2022.04.012] [Reference Citation Analysis]
91 Nicosia RF, Ligresti G, Caporarello N, Akilesh S, Ribatti D. COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury. Am J Pathol 2021;191:1374-84. [PMID: 34033751 DOI: 10.1016/j.ajpath.2021.05.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
92 Duan K, Premi E, Pilotto A, Cristillo V, Benussi A, Libri I, Giunta M, Bockholt HJ, Liu J, Campora R, Pezzini A, Gasparotti R, Magoni M, Padovani A, Calhoun VD. Alterations of frontal-temporal gray matter volume associate with clinical measures of older adults with COVID-19. Neurobiol Stress 2021;14:100326. [PMID: 33869679 DOI: 10.1016/j.ynstr.2021.100326] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
93 Pajo AT, Espiritu AI, Apor ADAO, Jamora RDG. Neuropathologic findings of patients with COVID-19: a systematic review. Neurol Sci 2021;42:1255-66. [PMID: 33483885 DOI: 10.1007/s10072-021-05068-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
94 Serrano GE, Walker JE, Arce R, Glass MJ, Vargas D, Sue LI, Intorcia AJ, Nelson CM, Oliver J, Papa J, Russell A, Suszczewicz KE, Borja CI, Belden C, Goldfarb D, Shprecher D, Atri A, Adler CH, Shill HA, Driver-Dunckley E, Mehta SH, Readhead B, Huentelman MJ, Peters JL, Alevritis E, Bimi C, Mizgerd JP, Reiman EM, Montine TJ, Desforges M, Zehnder JL, Sahoo MK, Zhang H, Solis D, Pinsky BA, Deture M, Dickson DW, Beach TG. Mapping of SARS-CoV-2 Brain Invasion and Histopathology in COVID-19 Disease. medRxiv 2021:2021. [PMID: 33619496 DOI: 10.1101/2021.02.15.21251511] [Cited by in Crossref: 10] [Cited by in F6Publishing: 1] [Article Influence: 10.0] [Reference Citation Analysis]
95 Curros Mata N, Alvarado de la Torre S, Carballo Fernández J, Martínez Morán A, Álvarez Refojo F, Rama-Maceiras P. Late bilateral vocal cord palsy following endotracheal intubation due to COVID-19 pneumonia. Rev Esp Anestesiol Reanim (Engl Ed) 2020:S0034-9356(20)30322-4. [PMID: 33558055 DOI: 10.1016/j.redar.2020.11.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
96 Reyes MSS, Medina PMB. Environmental pollutant exposure can exacerbate COVID-19 neurologic symptoms. Med Hypotheses 2020;144:110136. [PMID: 32771941 DOI: 10.1016/j.mehy.2020.110136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Umapathi T, Quek WMJ, Yen JM, Khin HSW, Mah YY, Chan CYJ, Ling LM, Yu WY. Encephalopathy in COVID-19 patients; viral, parainfectious, or both? eNeurologicalSci 2020;21:100275. [PMID: 32984561 DOI: 10.1016/j.ensci.2020.100275] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
98 Quarleri J, Delpino MV. SARS-CoV-2 interacts with renin-angiotensin system: impact on the central nervous system in elderly patients. Geroscience 2022. [PMID: 35157210 DOI: 10.1007/s11357-022-00528-0] [Reference Citation Analysis]
99 Chandra A, Johri A. A Peek into Pandora’s Box: COVID-19 and Neurodegeneration. Brain Sciences 2022;12:190. [DOI: 10.3390/brainsci12020190] [Reference Citation Analysis]
100 Mahapure KS, Prabhune AS, Chouvhan AV. COVID-19-Associated Acute Disseminated Encephalomyelitis: A Systematic Review. Asian J Neurosurg 2021;16:457-69. [PMID: 34660355 DOI: 10.4103/ajns.AJNS_406_20] [Reference Citation Analysis]
101 Sashindranath M, Nandurkar HH. Endothelial Dysfunction in the Brain: Setting the Stage for Stroke and Other Cerebrovascular Complications of COVID-19. Stroke 2021;52:1895-904. [PMID: 33794655 DOI: 10.1161/STROKEAHA.120.032711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
102 Bösel J, Berlit P. Neurologische Auswirkungen von COVID-19. DGNeurologie 2020;3:277-84. [DOI: 10.1007/s42451-020-00191-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
103 Kulkarni PG, Sakharkar A, Banerjee T. Understanding the role of nACE2 in neurogenic hypertension among COVID-19 patients. Hypertens Res 2021. [PMID: 34848886 DOI: 10.1038/s41440-021-00800-4] [Reference Citation Analysis]
104 Rehmani R, Segan S, Maddika SR, Lei YW, Broka A. Spectrum of neurologic & neuroimaging manifestation in COVID-19. Brain Behav Immun Health 2021;13:100238. [PMID: 33681827 DOI: 10.1016/j.bbih.2021.100238] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
105 Morgello S. Coronaviruses and the central nervous system. J Neurovirol 2020;26:459-73. [PMID: 32737861 DOI: 10.1007/s13365-020-00868-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
106 Kgatle MM, Lawal IO, Mashabela G, Boshomane TMG, Koatale PC, Mahasha PW, Ndlovu H, Vorster M, Rodrigues HG, Zeevaart JR, Gordon S, Moura-Alves P, Sathekge MM. COVID-19 Is a Multi-Organ Aggressor: Epigenetic and Clinical Marks. Front Immunol 2021;12:752380. [PMID: 34691068 DOI: 10.3389/fimmu.2021.752380] [Reference Citation Analysis]
107 Marcic L, Marcic M, Kojundzic SL, Marcic B, Capkun V, Vukojevic K. Personalized Approach to Patient with MRI Brain Changes after SARS-CoV-2 Infection. J Pers Med 2021;11:442. [PMID: 34063824 DOI: 10.3390/jpm11060442] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
108 Schweitzer F, Kleineberg NN, Göreci Y, Onur OA, Franke C, Warnke C. Neuro-COVID-19 is more than anosmia: clinical presentation, neurodiagnostics, therapies, and prognosis. Curr Opin Neurol 2021;34:423-31. [PMID: 33709973 DOI: 10.1097/WCO.0000000000000930] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
109 Behzadipour Y, Gholampour M, Pirhadi S, Seradj H, Khoshneviszadeh M, Hemmati S. Viral 3CLpro as a Target for Antiviral Intervention Using Milk-Derived Bioactive Peptides. Int J Pept Res Ther 2021;:1-14. [PMID: 34548852 DOI: 10.1007/s10989-021-10284-y] [Reference Citation Analysis]
110 Høy Marbjerg L, Jacobsen C, Fonager J, Bøgelund C, Rasmussen M, Fomsgaard A, Banner J, Vorobieva Solholm Jensen V. Possible Involvement of Central Nervous System in COVID-19 and Sequence Variability of SARS-CoV-2 Revealed in Autopsy Tissue Samples: A Case Report. Clin Pathol 2021;14:2632010X211006096. [PMID: 33855294 DOI: 10.1177/2632010X211006096] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
111 Seehusen F, Clark JJ, Sharma P, Bentley EG, Kirby A, Subramaniam K, Wunderlin-giuliani S, Hughes GL, Patterson EI, Michael BD, Owen A, Hiscox JA, Stewart JP, Kipar A. Neuroinvasion and Neurotropism by SARS-CoV-2 Variants in the K18-hACE2 Mouse. Viruses 2022;14:1020. [DOI: 10.3390/v14051020] [Reference Citation Analysis]
112 Aggarwal A, Singhal T, Bhatt M. Neurology and COVID-19: Acting now. Preparing for Future. Ann Indian Acad Neurol 2020;23:433-40. [PMID: 33223658 DOI: 10.4103/aian.AIAN_513_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
113 Synowiec A, Szczepański A, Barreto-Duran E, Lie LK, Pyrc K. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): a Systemic Infection. Clin Microbiol Rev 2021;34:e00133-20. [PMID: 33441314 DOI: 10.1128/CMR.00133-20] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
114 Chan C, Foster ST, Chan KG, Cacace MJ, Ladd SL, Sandum CT, Wright PT, Volmert B, Yang W, Aguirre A, Li W, Wright NT. Repositioned Drugs for COVID-19-the Impact on Multiple Organs. SN Compr Clin Med 2021;:1-18. [PMID: 33898925 DOI: 10.1007/s42399-021-00874-8] [Reference Citation Analysis]
115 Ong WY, Go ML, Wang DY, Cheah IK, Halliwell B. Effects of Antimalarial Drugs on Neuroinflammation-Potential Use for Treatment of COVID-19-Related Neurologic Complications. Mol Neurobiol 2021;58:106-17. [PMID: 32897518 DOI: 10.1007/s12035-020-02093-z] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
116 Ai J, Hong W, Wu M, Wei X. Pulmonary vascular system: A vulnerable target for COVID-19. MedComm (2020) 2021. [PMID: 34909758 DOI: 10.1002/mco2.94] [Reference Citation Analysis]
117 Nalugo M, Schulte LJ, Masood MF, Zayed MA. Microvascular Angiopathic Consequences of COVID-19. Front Cardiovasc Med 2021;8:636843. [PMID: 33604359 DOI: 10.3389/fcvm.2021.636843] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
118 Zhao Y, Liu Y, Yi F, Zhang J, Xu Z, Liu Y, Tao Y. Type 2 diabetes mellitus impaired nasal immunity and increased the risk of hyposmia in COVID-19 mild pneumonia patients. Int Immunopharmacol 2021;93:107406. [PMID: 33601246 DOI: 10.1016/j.intimp.2021.107406] [Reference Citation Analysis]
119 Alonso-Bellido IM, Bachiller S, Vázquez G, Cruz-Hernández L, Martínez E, Ruiz-Mateos E, Deierborg T, Venero JL, Real LM, Ruiz R. The Other Side of SARS-CoV-2 Infection: Neurological Sequelae in Patients. Front Aging Neurosci 2021;13:632673. [PMID: 33889082 DOI: 10.3389/fnagi.2021.632673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
120 Chigr F, Merzouki M, Najimi M. Comment on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients". J Med Virol 2020;92:703-4. [PMID: 32352575 DOI: 10.1002/jmv.25960] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 10.0] [Reference Citation Analysis]
121 Finsterer J, Scorza FA, Ghosh R. COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid. J Med Virol 2021;93:66-8. [PMID: 32497288 DOI: 10.1002/jmv.26121] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
122 Huth SF, Cho SM, Robba C, Highton D, Battaglini D, Bellapart J, Suen JY, Li Bassi G, Taccone FS, Arora RC, Whitman G, Fraser JF, Fanning JP. Neurological Manifestations of Coronavirus Disease 2019: A Comprehensive Review and Meta-Analysis of the First 6 Months of Pandemic Reporting. Front Neurol 2021;12:664599. [PMID: 34456840 DOI: 10.3389/fneur.2021.664599] [Reference Citation Analysis]
123 Martins-Filho PR, Pereira de Andrade AL, Pereira de Andrade AJ, Moura da Silva MD, de Souza Araújo AA, Nunes PS, Santos VS, Ferreira LC, de Aquino Neves EL, Quintans-Júnior LJ. Miller Fisher Syndrome in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Systematic Review. J Clin Neurol 2021;17:541-5. [PMID: 34595862 DOI: 10.3988/jcn.2021.17.4.541] [Reference Citation Analysis]
124 Mahboubi Mehrabani M, Karvandi MS, Maafi P, Doroudian M. Neurological complications associated with Covid-19; molecular mechanisms and therapeutic approaches. Rev Med Virol 2022;:e2334. [PMID: 35138001 DOI: 10.1002/rmv.2334] [Reference Citation Analysis]
125 Orrù G, Conversano C, Malloggi E, Francesconi F, Ciacchini R, Gemignani A. Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review. Int J Environ Res Public Health 2020;17:E6688. [PMID: 32937949 DOI: 10.3390/ijerph17186688] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 5.5] [Reference Citation Analysis]
126 Generoso JS, Barichello de Quevedo JL, Cattani M, Lodetti BF, Sousa L, Collodel A, Diaz AP, Dal-Pizzol F. Neurobiology of COVID-19: how can the virus affect the brain? Braz J Psychiatry 2021:S1516-44462021005003203. [PMID: 33605367 DOI: 10.1590/1516-4446-2020-1488] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
127 Tavčar P, Potokar M, Kolenc M, Korva M, Avšič-Županc T, Zorec R, Jorgačevski J. Neurotropic Viruses, Astrocytes, and COVID-19. Front Cell Neurosci 2021;15:662578. [PMID: 33897376 DOI: 10.3389/fncel.2021.662578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
128 Radmard S, Epstein SE, Roeder HJ, Michalak AJ, Shapiro SD, Boehme A, Wilson TJ, Duran JC, Bain JM, Willey JZ, Thakur KT. Inpatient Neurology Consultations During the Onset of the SARS-CoV-2 New York City Pandemic: A Single Center Case Series. Front Neurol 2020;11:805. [PMID: 32754113 DOI: 10.3389/fneur.2020.00805] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
129 Meacci E, Garcia-Gil M, Pierucci F. SARS-CoV-2 Infection: A Role for S1P/S1P Receptor Signaling in the Nervous System? Int J Mol Sci 2020;21:E6773. [PMID: 32942748 DOI: 10.3390/ijms21186773] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
130 Fiel MI, El Jamal SM, Paniz-Mondolfi A, Gordon RE, Reidy J, Bandovic J, Advani R, Kilaru S, Pourmand K, Ward S, Thung SN, Schiano T. Findings of Severe Hepatic Severe Acute Respiratory Syndrome Coronavirus-2 Infection. Cell Mol Gastroenterol Hepatol. 2021;1-8. [PMID: 32992052 DOI: 10.1016/j.jcmgh.2020.09.015] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
131 Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M, Bella R, Lanza G, Mansueto G. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health 2021;18:1415. [PMID: 33546463 DOI: 10.3390/ijerph18041415] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
132 Bikson M, Hanlon CA, Woods AJ, Gillick BT, Charvet L, Lamm C, Madeo G, Holczer A, Almeida J, Antal A, Ay MR, Baeken C, Blumberger DM, Campanella S, Camprodon JA, Christiansen L, Loo C, Crinion JT, Fitzgerald P, Gallimberti L, Ghobadi-Azbari P, Ghodratitoostani I, Grabner RH, Hartwigsen G, Hirata A, Kirton A, Knotkova H, Krupitsky E, Marangolo P, Nakamura-Palacios EM, Potok W, Praharaj SK, Ruff CC, Schlaug G, Siebner HR, Stagg CJ, Thielscher A, Wenderoth N, Yuan TF, Zhang X, Ekhtiari H. Guidelines for TMS/tES clinical services and research through the COVID-19 pandemic. Brain Stimul 2020;13:1124-49. [PMID: 32413554 DOI: 10.1016/j.brs.2020.05.010] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 14.0] [Reference Citation Analysis]
133 Tsai ST, Lu MK, San S, Tsai CH. The Neurologic Manifestations of Coronavirus Disease 2019 Pandemic: A Systemic Review. Front Neurol. 2020;11:498. [PMID: 32574246 DOI: 10.3389/fneur.2020.00498] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 18.0] [Reference Citation Analysis]
134 Hawkins M, Sockalingam S, Bonato S, Rajaratnam T, Ravindran M, Gosse P, Sheehan KA. A rapid review of the pathoetiology, presentation, and management of delirium in adults with COVID-19. J Psychosom Res 2021;141:110350. [PMID: 33401078 DOI: 10.1016/j.jpsychores.2020.110350] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
135 Nouri-Vaskeh M, Sharifi A, Khalili N, Zand R, Sharifi A. Dyspneic and non-dyspneic (silent) hypoxemia in COVID-19: Possible neurological mechanism. Clin Neurol Neurosurg 2020;198:106217. [PMID: 32947193 DOI: 10.1016/j.clineuro.2020.106217] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 11.5] [Reference Citation Analysis]
136 Cheraghali F, Tahamtan A, Hosseini SA, Gharib MH, Moradi A, Razavi Nikoo H, Tabarraei A. Case Report: Detection of SARS-CoV-2 From Cerebrospinal Fluid in a 34-Month-Old Child With Encephalitis. Front Pediatr 2021;9:565778. [PMID: 33959568 DOI: 10.3389/fped.2021.565778] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
137 Pyne JD, Brickman AM. The Impact of the COVID-19 Pandemic on Dementia Risk: Potential Pathways to Cognitive Decline. Neurodegener Dis 2021;21:1-23. [PMID: 34348321 DOI: 10.1159/000518581] [Reference Citation Analysis]
138 Simões JLB, de Araújo JB, Bagatini MD. Anti-inflammatory Therapy by Cholinergic and Purinergic Modulation in Multiple Sclerosis Associated with SARS-CoV-2 Infection. Mol Neurobiol 2021. [PMID: 34247339 DOI: 10.1007/s12035-021-02464-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
139 Vavougios GD, Zarogiannis SG, Hadjigeorgiou G, Krogfelt KA, Gourgoulianis KI. SARS-CoV-2 and type I interferon signaling in brain endothelial cells: Blurring the lines between friend or foe. Stem Cell Reports 2022;17:1012-3. [PMID: 35545022 DOI: 10.1016/j.stemcr.2022.04.011] [Reference Citation Analysis]
140 Dixon L, Coughlan C, Karunaratne K, Gorgoraptis N, Varley J, Husselbee J, Mallon D, Carroll R, Jones B, Boynton C, Pritchard J, Youngstein T, Mason J, Gabriel C. Immunosuppression for intracranial vasculitis associated with SARS-CoV-2: therapeutic implications for COVID-19 cerebrovascular pathology. J Neurol Neurosurg Psychiatry 2020:jnnp-2020-324291. [PMID: 32855293 DOI: 10.1136/jnnp-2020-324291] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
141 Pezzini A, Padovani A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol 2020;16:636-44. [PMID: 32839585 DOI: 10.1038/s41582-020-0398-3] [Cited by in Crossref: 112] [Cited by in F6Publishing: 122] [Article Influence: 56.0] [Reference Citation Analysis]
142 Finsterer J, Scorza FA. Infectious and immune-mediated central nervous system disease in 48 COVID-19 patients. J Clin Neurosci 2021;90:140-3. [PMID: 34275539 DOI: 10.1016/j.jocn.2021.05.065] [Reference Citation Analysis]
143 Förster M, Weyers V, Küry P, Barnett M, Hartung HP, Kremer D. Neurological manifestations of severe acute respiratory syndrome coronavirus 2-a controversy 'gone viral'. Brain Commun 2020;2:fcaa149. [PMID: 33210085 DOI: 10.1093/braincomms/fcaa149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
144 Finsterer J, Scorza FA. Presence of Severe Acute Respiratory Syndrome Coronavirus 2 in the Cerebrospinal Fluid of Guillain-Barré Syndrome Patients Requires Validation. Pediatr Infect Dis J 2021;40:e527. [PMID: 34338233 DOI: 10.1097/INF.0000000000003287] [Reference Citation Analysis]
145 Jackson NR, Zeigler K, Torrez M, Makino Y, Adolphi NL, Lathrop S, Decker L, Dvorscak L, Proe L, Paul ID, Zumwalt R, Jarrell H. New Mexico's COVID-19 Experience. Am J Forensic Med Pathol 2021;42:1-8. [PMID: 33416234 DOI: 10.1097/PAF.0000000000000664] [Reference Citation Analysis]
146 Osorio C, Sfera A, Anton JJ, Thomas KG, Andronescu CV, Li E, Yahia RW, Avalos AG, Kozlakidis Z. Virus-Induced Membrane Fusion in Neurodegenerative Disorders. Front Cell Infect Microbiol 2022;12:845580. [DOI: 10.3389/fcimb.2022.845580] [Reference Citation Analysis]
147 Baig AM. Counting the neurological cost of COVID-19. Nat Rev Neurol 2021. [PMID: 34795449 DOI: 10.1038/s41582-021-00593-7] [Reference Citation Analysis]
148 Khatoon F, Prasad K, Kumar V. Neurological manifestations of COVID-19: available evidences and a new paradigm. J Neurovirol 2020;26:619-30. [PMID: 32839951 DOI: 10.1007/s13365-020-00895-4] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 12.5] [Reference Citation Analysis]
149 Lamontagne SJ, Pizzagalli DA, Olmstead MC. Does inflammation link stress to poor COVID-19 outcome? Stress Health 2021;37:401-14. [PMID: 33315291 DOI: 10.1002/smi.3017] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
150 Ondek K, Nasirishargh A, Dayton JR, Nuño MA, Cruz-Orengo L. Strain and sex differences in somatosensation and sociability during experimental autoimmune encephalomyelitis. Brain Behav Immun Health 2021;14:100262. [PMID: 34589768 DOI: 10.1016/j.bbih.2021.100262] [Reference Citation Analysis]
151 Marazziti D, Cianconi P, Mucci F, Foresi L, Chiarantini I, Della Vecchia A. Climate change, environment pollution, COVID-19 pandemic and mental health. Sci Total Environ 2021;773:145182. [PMID: 33940721 DOI: 10.1016/j.scitotenv.2021.145182] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
152 Flores-Pliego A, Miranda J, Vega-Torreblanca S, Valdespino-Vázquez Y, Helguera-Repetto C, Espejel-Nuñez A, Borboa-Olivares H, Espino Y Sosa S, Mateu-Rogell P, León-Juárez M, Ramírez-Santes V, Cardona-Pérez A, Villegas-Mota I, Torres-Torres J, Juárez-Reyes Á, Rizo-Pica T, González RO, González-Mariscal L, Estrada-Gutierrez G. Molecular Insights into the Thrombotic and Microvascular Injury in Placental Endothelium of Women with Mild or Severe COVID-19. Cells 2021;10:364. [PMID: 33578631 DOI: 10.3390/cells10020364] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
153 Ray STJ, Abdel-Mannan O, Sa M, Fuller C, Wood GK, Pysden K, Yoong M, McCullagh H, Scott D, McMahon M, Thomas N, Taylor M, Illingworth M, McCrea N, Davies V, Whitehouse W, Zuberi S, Guthrie K, Wassmer E, Shah N, Baker MR, Tiwary S, Tan HJ, Varma U, Ram D, Avula S, Enright N, Hassell J, Ross Russell AL, Kumar R, Mulholland RE, Pett S, Galea I, Thomas RH, Lim M, Hacohen Y, Solomon T, Griffiths MJ, Michael BD, Kneen R; CoroNerve study group. Neurological manifestations of SARS-CoV-2 infection in hospitalised children and adolescents in the UK: a prospective national cohort study. Lancet Child Adolesc Health 2021;5:631-41. [PMID: 34273304 DOI: 10.1016/S2352-4642(21)00193-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
154 Kajumba MM, Kolls BJ, Koltai DC, Kaddumukasa M, Kaddumukasa M, Laskowitz DT. COVID-19-Associated Guillain-Barre Syndrome: Atypical Para-infectious Profile, Symptom Overlap, and Increased Risk of Severe Neurological Complications. SN Compr Clin Med 2020;:1-13. [PMID: 33251483 DOI: 10.1007/s42399-020-00646-w] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
155 Azab MA, Azzam AY, Salem AE, Reda A, Hassanein SF, Sabra M, Gadelmoula IS. Neurological problems in the context of COVID-19 infection in Egypt. A multicenter retrospective analysis. Interdiscip Neurosurg 2021;26:101345. [PMID: 34426783 DOI: 10.1016/j.inat.2021.101345] [Reference Citation Analysis]
156 Damiano RF, Guedes BF, de Rocca CC, de Pádua Serafim A, Castro LHM, Munhoz CD, Nitrini R, Filho GB, Miguel EC, Lucchetti G, Forlenza O. Cognitive decline following acute viral infections: literature review and projections for post-COVID-19. Eur Arch Psychiatry Clin Neurosci 2021. [PMID: 34173049 DOI: 10.1007/s00406-021-01286-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Rodriguez M, Soler Y, Perry M, Reynolds JL, El-Hage N. Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in the Nervous System: Implications of COVID-19 in Neurodegeneration. Front Neurol 2020;11:583459. [PMID: 33304309 DOI: 10.3389/fneur.2020.583459] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
158 Araújo NM, Ferreira LC, Dantas DP, Silva DS, Dos Santos CA, Cipolotti R, Martins-Filho PR. First Report of SARS-CoV-2 Detection in Cerebrospinal Fluid in a Child With Guillain-Barré Syndrome. Pediatr Infect Dis J 2021;40:e274-6. [PMID: 33990525 DOI: 10.1097/INF.0000000000003146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
159 Rebholz H, Pfaffeneder-Mantai F, Knoll W, Hassel AW, Frank W, Kleber C. Olfactory dysfunction in SARS-CoV-2 infection: Focus on odorant specificity and chronic persistence. Am J Otolaryngol 2021;42:103014. [PMID: 33873048 DOI: 10.1016/j.amjoto.2021.103014] [Reference Citation Analysis]
160 Fan S, Xiao M, Han F, Xia P, Bai X, Chen H, Zhang H, Ding X, Zhao H, Zhao J, Sun X, Jiang W, Wang C, Cao W, Guo F, Tian R, Gao P, Wu W, Ma J, Wu D, Liu Z, Zhou X, Wang J, Guan T, Qin Y, Li T, Xu Y, Zhang D, Chen Y, Xie J, Li Y, Yan X, Zhu Y, Peng B, Cui L, Zhang S, Guan H. Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study. Front Neurol 2020;11:806. [PMID: 32754114 DOI: 10.3389/fneur.2020.00806] [Cited by in Crossref: 33] [Cited by in F6Publishing: 28] [Article Influence: 16.5] [Reference Citation Analysis]
161 Wang L, Shen Y, Li M, Chuang H, Ye Y, Zhao H, Wang H. Clinical manifestations and evidence of neurological involvement in 2019 novel coronavirus SARS-CoV-2: a systematic review and meta-analysis. J Neurol 2020;267:2777-89. [PMID: 32529575 DOI: 10.1007/s00415-020-09974-2] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 30.0] [Reference Citation Analysis]
162 Uversky VN, Elrashdy F, Aljadawi A, Ali SM, Khan RH, Redwan EM. Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How? J Neurosci Res 2021;99:750-77. [PMID: 33217763 DOI: 10.1002/jnr.24752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
163 Mirzaei S, Kulkarni K, Zhou K, Crack PJ, Aguilar MI, Finkelstein DI, Forsythe JS. Biomaterial Strategies for Restorative Therapies in Parkinson's Disease. ACS Chem Neurosci 2021;12:4224-35. [PMID: 34634903 DOI: 10.1021/acschemneuro.1c00484] [Reference Citation Analysis]
164 Bullock HA, Goldsmith CS, Zaki SR, Martines RB, Miller SE. Difficulties in Differentiating Coronaviruses from Subcellular Structures in Human Tissues by Electron Microscopy. Emerg Infect Dis 2021;27:1023-31. [PMID: 33600302 DOI: 10.3201/eid2704.204337] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 13.0] [Reference Citation Analysis]
165 Hu J, Jolkkonen J, Zhao C. Neurotropism of SARS-CoV-2 and its neuropathological alterations: Similarities with other coronaviruses. Neurosci Biobehav Rev 2020;119:184-93. [PMID: 33091416 DOI: 10.1016/j.neubiorev.2020.10.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
166 Porta-Etessam J, Matías-Guiu JA, González-García N, Gómez Iglesias P, Santos-Bueso E, Arriola-Villalobos P, García-Azorín D, Matías-Guiu J. Spectrum of Headaches Associated With SARS-CoV-2 Infection: Study of Healthcare Professionals. Headache 2020;60:1697-704. [PMID: 32666513 DOI: 10.1111/head.13902] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 12.5] [Reference Citation Analysis]
167 Williams ME, Fielding BC. Insult to Injury-Potential Contribution of Coronavirus Disease-19 to Neuroinflammation and the Development of HIV-Associated Neurocognitive Disorders. AIDS Res Hum Retroviruses 2021;37:601-9. [PMID: 32993321 DOI: 10.1089/AID.2020.0136] [Reference Citation Analysis]
168 Elgamasy S, Kamel MG, Ghozy S, Khalil A, Morra ME, Islam SMS. First case of focal epilepsy associated with SARS-coronavirus-2. J Med Virol 2020;92:2238-42. [PMID: 32484990 DOI: 10.1002/jmv.26113] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 12.0] [Reference Citation Analysis]
169 Ljubimov VA, Ramesh A, Davani S, Danielpour M, Breunig JJ, Black KL. Neurosurgery at the crossroads of immunology and nanotechnology. New reality in the COVID-19 pandemic. Adv Drug Deliv Rev 2021;:114033. [PMID: 34808227 DOI: 10.1016/j.addr.2021.114033] [Reference Citation Analysis]
170 Beeraka NM, Tulimilli SV, Karnik M, Sadhu SP, Pragada RR, Aliev G, Madhunapantula SV. The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2). Biomed Res Int 2021;2021:8160860. [PMID: 34159203 DOI: 10.1155/2021/8160860] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
171 Leis-Cofiño C, Arriero-Sánchez P, González-Herranz R, Arenas-Brítez Ó, Hernández-García E, Plaza G. Persistent Dysphonia in Hospitalized COVID-19 Patients. J Voice 2021:S0892-1997(21)00234-4. [PMID: 34384660 DOI: 10.1016/j.jvoice.2021.07.001] [Reference Citation Analysis]
172 Baig AM. Computing the Effects of SARS-CoV-2 on Respiration Regulatory Mechanisms in COVID-19. ACS Chem Neurosci 2020;11:2416-21. [PMID: 32600045 DOI: 10.1021/acschemneuro.0c00349] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
173 Muro I, Ramos C, Barbosa A, Vivancos J. Haemorrhage within the cavity of a porencephalic cyst: a haemorrhagic complication in a patient with COVID-19. Neurologia (Engl Ed) 2022:S2173-5808(22)00043-8. [PMID: 35527108 DOI: 10.1016/j.nrleng.2021.09.003] [Reference Citation Analysis]
174 Bahranifard B, Mehdizadeh S, Hamidi A, Khosravi A, Emami R, Mirzaei K, Nemati R, Nemati F, Assadi M, Gholamrezanezhad A. A review of neuroradiological abnormalities in patients with coronavirus disease 2019 (COVID-19). Neuroradiol J 2021;:19714009211029177. [PMID: 34224248 DOI: 10.1177/19714009211029177] [Reference Citation Analysis]
175 Waszkiewicz N. Possible special needs for mental online support in female and male health care workers during the COVID-19. J Med Virol 2021;93:174-5. [PMID: 32639619 DOI: 10.1002/jmv.26273] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
176 Nikbakht F, Mohammadkhanizadeh A, Mohammadi E. How does the COVID-19 cause seizure and epilepsy in patients? The potential mechanisms. Mult Scler Relat Disord 2020;46:102535. [PMID: 33010584 DOI: 10.1016/j.msard.2020.102535] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 10.5] [Reference Citation Analysis]
177 Kim HK, Cho YJ, Lee SY. Neurological Manifestations in Patients with COVID-19: Experiences from the Central Infectious Diseases Hospital in South Korea. J Clin Neurol 2021;17:435-42. [PMID: 34184452 DOI: 10.3988/jcn.2021.17.3.435] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Galea M, Agius M, Vassallo N. Neurological manifestations and pathogenic mechanisms of COVID-19. Neurol Res 2022;:1-12. [PMID: 34986754 DOI: 10.1080/01616412.2021.2024732] [Reference Citation Analysis]
179 Attia AS, Hussein M, Aboueisha MA, Omar M, Youssef MR, Mankowski N, Miller M, Munshi R, Swinford A, Kline A, Nguyen T, Toraih E, Duchesne J, Kandil E. Altered mental status is a predictor of poor outcomes in COVID-19 patients: A cohort study. PLoS One 2021;16:e0258095. [PMID: 34610034 DOI: 10.1371/journal.pone.0258095] [Reference Citation Analysis]
180 Meshref M, Hewila IM, Abdel Mageed S, Morra ME. COVID-19 Associated With Encephalitis: Case Report and Review of Literature. Neurologist 2021;26:268-70. [PMID: 34734905 DOI: 10.1097/NRL.0000000000000347] [Reference Citation Analysis]
181 Campos MR, Schramm JMA, Emmerick ICM, Rodrigues JM, Avelar FG, Pimentel TG. Burden of disease from COVID-19 and its acute and chronic complications: reflections on measurement (DALYs) and prospects for the Brazilian Unified National Health System. Cad Saude Publica 2020;36:e00148920. [PMID: 33146278 DOI: 10.1590/0102-311X00148920] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
182 Beauchamp LC, Finkelstein DI, Bush AI, Evans AH, Barnham KJ. Parkinsonism as a Third Wave of the COVID-19 Pandemic? J Parkinsons Dis 2020;10:1343-53. [PMID: 32986683 DOI: 10.3233/JPD-202211] [Cited by in Crossref: 16] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]
183 Chua TH, Xu Z, King NKK. Neurological manifestations in COVID-19: a systematic review and meta-analysis. Brain Inj 2020;34:1549-68. [PMID: 33074036 DOI: 10.1080/02699052.2020.1831606] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
184 Wenzel J, Lampe J, Müller-Fielitz H, Schuster R, Zille M, Müller K, Krohn M, Körbelin J, Zhang L, Özorhan Ü, Neve V, Wagner JUG, Bojkova D, Shumliakivska M, Jiang Y, Fähnrich A, Ott F, Sencio V, Robil C, Pfefferle S, Sauve F, Coêlho CFF, Franz J, Spiecker F, Lembrich B, Binder S, Feller N, König P, Busch H, Collin L, Villaseñor R, Jöhren O, Altmeppen HC, Pasparakis M, Dimmeler S, Cinatl J, Püschel K, Zelic M, Ofengeim D, Stadelmann C, Trottein F, Nogueiras R, Hilgenfeld R, Glatzel M, Prevot V, Schwaninger M. The SARS-CoV-2 main protease Mpro causes microvascular brain pathology by cleaving NEMO in brain endothelial cells. Nat Neurosci 2021;24:1522-33. [PMID: 34675436 DOI: 10.1038/s41593-021-00926-1] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
185 Gomez-Pinedo U, Matias-Guiu J, Sanclemente-Alaman I, Moreno-Jimenez L, Montero-Escribano P, Matias-Guiu JA. Is the brain a reservoir organ for SARS-CoV2? J Med Virol 2020;92:2354-5. [PMID: 32437002 DOI: 10.1002/jmv.26046] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
186 Ritschel N, Radbruch H, Herden C, Schneider N, Dittmayer C, Franz J, Thomas C, Silva Boos G, Pagenstecher A, Schulz-Schaeffer W, Stadelmann C, Glatzel M, Heppner FL, Weis J, Sohrabi K, Schänzer A, Németh A, Acker T; DGNN-Taskforce „CNS-COVID19“., „DEFEAT PANDEMIcs – Neuropathologische Referenzdiagnostik bei COVID-19“. [COVID-19 and the central and peripheral nervous system]. Pathologe 2021;42:172-82. [PMID: 33646363 DOI: 10.1007/s00292-021-00924-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
187 Hernández-Fernández F, Sandoval Valencia H, Barbella-Aponte RA, Collado-Jiménez R, Ayo-Martín Ó, Barrena C, Molina-Nuevo JD, García-García J, Lozano-Setién E, Alcahut-Rodriguez C, Martínez-Martín Á, Sánchez-López A, Segura T. Cerebrovascular disease in patients with COVID-19: neuroimaging, histological and clinical description. Brain 2020;143:3089-103. [PMID: 32645151 DOI: 10.1093/brain/awaa239] [Cited by in Crossref: 107] [Cited by in F6Publishing: 86] [Article Influence: 53.5] [Reference Citation Analysis]
188 Frontera JA, Lewis A, Yaghi S, Bhimraj A. Reader Response: Acute Necrotizing Encephalopathy With SARS-CoV-2 RNA Confirmed in Cerebrospinal Fluid. Neurology 2021;97:252. [PMID: 34341078 DOI: 10.1212/WNL.0000000000012357] [Reference Citation Analysis]
189 Al-Ramadan A, Rabab'h O, Shah J, Gharaibeh A. Acute and Post-Acute Neurological Complications of COVID-19. Neurol Int 2021;13:102-19. [PMID: 33803475 DOI: 10.3390/neurolint13010010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
190 Mahdizade Ari M, Mohamadi MH, Shadab Mehr N, Abbasimoghaddam S, Shekartabar A, Heidary M, Khoshnood S. Neurological manifestations in patients with COVID-19: A systematic review and meta-analysis. J Clin Lab Anal 2022;:e24403. [PMID: 35385200 DOI: 10.1002/jcla.24403] [Reference Citation Analysis]
191 Ivanova GE, Bogolepova AN, Levin OS, Shamalov NA, Khasanova DR, Yanishevsky SN, Zakharov VV, Khatkova SE, Stakhovskya LV. [Current issues of treatment and rehabilitation of patients with neurological disorders and the consequences of COVID-19. Resolution of Advisory Board]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:145-51. [PMID: 34283545 DOI: 10.17116/jnevro2021121061145] [Reference Citation Analysis]
192 Vacaras V, Frunze S, Cordos AM. Neurological complications in COVID-19 - a diagnostic challenge. J Med Life 2021;14:216-24. [PMID: 34104245 DOI: 10.25122/jml-2021-0045] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
193 González-Zamora J, Bilbao-Malavé V, Gándara E, Casablanca-Piñera A, Boquera-Ventosa C, Landecho MF, Zarranz-Ventura J, García-Layana A. Retinal Microvascular Impairment in COVID-19 Bilateral Pneumonia Assessed by Optical Coherence Tomography Angiography. Biomedicines 2021;9:247. [PMID: 33801324 DOI: 10.3390/biomedicines9030247] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
194 Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen Á, Layos-Romero A, García-García J, González E, Redondo-Peñas I, Perona-Moratalla AB, Del Valle-Pérez JA, Gracia-Gil J, Rojas-Bartolomé L, Feria-Vilar I, Monteagudo M, Palao M, Palazón-García E, Alcahut-Rodríguez C, Sopelana-Garay D, Moreno Y, Ahmad J, Segura T. Neurologic manifestations in hospitalized patients with COVID-19: The ALBACOVID registry. Neurology 2020;95:e1060-70. [PMID: 32482845 DOI: 10.1212/WNL.0000000000009937] [Cited by in Crossref: 243] [Cited by in F6Publishing: 147] [Article Influence: 121.5] [Reference Citation Analysis]
195 Pennisi M, Lanza G, Falzone L, Fisicaro F, Ferri R, Bella R. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms. Int J Mol Sci 2020;21:E5475. [PMID: 32751841 DOI: 10.3390/ijms21155475] [Cited by in Crossref: 46] [Cited by in F6Publishing: 48] [Article Influence: 23.0] [Reference Citation Analysis]
196 Muro I, Ramos C, Barbosa A, Vivancos J. [Haemorrhage within the cavity of a porencephalic cyst: a haemorrhagic complication in a patient with COVID-19.]. Neurologia 2021. [PMID: 34725528 DOI: 10.1016/j.nrl.2021.09.004] [Reference Citation Analysis]
197 Walton DWA, Thakur KT, Venkatesan A, Breen G, Solomon T, Michael BD. Encephalitis in a Pandemic. Front Neurol 2021;12:637586. [PMID: 33643210 DOI: 10.3389/fneur.2021.637586] [Reference Citation Analysis]
198 Vallée A. Dysautonomia and Implications for Anosmia in Long COVID-19 Disease. J Clin Med 2021;10:5514. [PMID: 34884216 DOI: 10.3390/jcm10235514] [Reference Citation Analysis]
199 Burks SM, Rosas-Hernandez H, Alejandro Ramirez-Lee M, Cuevas E, Talpos JC. Can SARS-CoV-2 infect the central nervous system via the olfactory bulb or the blood-brain barrier? Brain Behav Immun 2021;95:7-14. [PMID: 33412255 DOI: 10.1016/j.bbi.2020.12.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
200 D'Errico S, Zanon M, Montanaro M, Radaelli D, Sessa F, Di Mizio G, Montana A, Corrao S, Salerno M, Pomara C. More than Pneumonia: Distinctive Features of SARS-Cov-2 Infection. From Autopsy Findings to Clinical Implications: A Systematic Review. Microorganisms 2020;8:E1642. [PMID: 33114061 DOI: 10.3390/microorganisms8111642] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 7.0] [Reference Citation Analysis]
201 de Erausquin GA, Snyder H, Carrillo M, Hosseini AA, Brugha TS, Seshadri S; CNS SARS-CoV-2 Consortium. The chronic neuropsychiatric sequelae of COVID-19: The need for a prospective study of viral impact on brain functioning. Alzheimers Dement 2021;17:1056-65. [PMID: 33399270 DOI: 10.1002/alz.12255] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 18.0] [Reference Citation Analysis]
202 Yan K, Xiao FF, Jiang YW, Xiao TT, Zhang DJ, Yuan WH, Shao JB, Cheng GQ, Zeng LK. Effects of SARS-CoV-2 infection on neuroimaging and neurobehavior in neonates. World J Pediatr 2021;17:171-9. [PMID: 33740237 DOI: 10.1007/s12519-021-00423-2] [Reference Citation Analysis]
203 Sharifian-Dorche M, Huot P, Osherov M, Wen D, Saveriano A, Giacomini PS, Antel JP, Mowla A. Neurological complications of coronavirus infection; a comparative review and lessons learned during the COVID-19 pandemic. J Neurol Sci 2020;417:117085. [PMID: 32871412 DOI: 10.1016/j.jns.2020.117085] [Cited by in Crossref: 47] [Cited by in F6Publishing: 52] [Article Influence: 23.5] [Reference Citation Analysis]
204 Rapalino O, Pourvaziri A, Maher M, Jaramillo-Cardoso A, Edlow BL, Conklin J, Huang S, Westover B, Romero JM, Halpern E, Gupta R, Pomerantz S, Schaefer P, Gonzalez RG, Mukerji SS, Lev MH. Clinical, Imaging, and Lab Correlates of Severe COVID-19 Leukoencephalopathy. AJNR Am J Neuroradiol 2021;42:632-8. [PMID: 33414226 DOI: 10.3174/ajnr.A6966] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
205 Tabary M, Khanmohammadi S, Araghi F, Dadkhahfar S, Tavangar SM. Pathologic features of COVID-19: A concise review. Pathol Res Pract. 2020;216:153097. [PMID: 32825963 DOI: 10.1016/j.prp.2020.153097] [Cited by in Crossref: 34] [Cited by in F6Publishing: 29] [Article Influence: 17.0] [Reference Citation Analysis]
206 Barreto-Filho JA, Seabra-Garcez JD, Garcez FB, Moreira TS, Drager LF. Nondyspnogenic acute hypoxemic respiratory failure in COVID-19 pneumonia. J Appl Physiol (1985) 2021;130:892-7. [PMID: 33031016 DOI: 10.1152/japplphysiol.00522.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
207 Yusuf F, Fahriani M, Mamada SS, Frediansyah A, Abubakar A, Maghfirah D, Fajar JK, Maliga HA, Ilmawan M, Emran TB, Ophinni Y, Innayah MR, Masyeni S, Ghouth ASB, Yusuf H, Dhama K, Nainu F, Harapan H. Global prevalence of prolonged gastrointestinal symptoms in COVID-19 survivors and potential pathogenesis: A systematic review and meta-analysis. F1000Res 2021;10:301. [PMID: 34131481 DOI: 10.12688/f1000research.52216.1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
208 Sanz-Canalejas L, Polidura-Arruga MDC, Yus-Fuertes M, Jorquera-Moya M, Vidart-Simón N, Arrazola-García J, Gómez-Ruiz N. Lesson of the month: Severe leukoencephalopathy by SARS-CoV-2. Clin Med (Lond) 2021;21:155-7. [PMID: 33762380 DOI: 10.7861/clinmed.2020-0940] [Reference Citation Analysis]
209 Babaei A, Iravani K, Malekpour B, Golkhar B, Soltaniesmaeili A, Hosseinialhashemi M. Factors associated with anosmia recovery rate in COVID-19 patients. Laryngoscope Investig Otolaryngol 2021. [PMID: 34909467 DOI: 10.1002/lio2.690] [Reference Citation Analysis]
210 Magusali N, Graham AC, Piers TM, Panichnantakul P, Yaman U, Shoai M, Reynolds RH, Botia JA, Brookes KJ, Guetta-Baranes T, Bellou E, Bayram S, Sokolova D, Ryten M, Sala Frigerio C, Escott-Price V, Morgan K, Pocock JM, Hardy J, Salih DA. A genetic link between risk for Alzheimer's disease and severe COVID-19 outcomes via the OAS1 gene. Brain 2021:awab337. [PMID: 34619763 DOI: 10.1093/brain/awab337] [Reference Citation Analysis]
211 Erickson MA, Rhea EM, Knopp RC, Banks WA. Interactions of SARS-CoV-2 with the Blood-Brain Barrier. Int J Mol Sci 2021;22:2681. [PMID: 33800954 DOI: 10.3390/ijms22052681] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
212 Prezioso C, Marcocci ME, Palamara AT, De Chiara G, Pietropaolo V. The "Three Italy" of the COVID-19 epidemic and the possible involvement of SARS-CoV-2 in triggering complications other than pneumonia. J Neurovirol 2020;26:311-23. [PMID: 32548750 DOI: 10.1007/s13365-020-00862-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
213 Stöllberger C, Finsterer J, Schneider B. Reduced standards of scientific reporting in the COVID-19 pandemic? Minerva Cardiol Angiol 2021;69:374-6. [PMID: 33146484 DOI: 10.23736/S2724-5683.20.05443-2] [Reference Citation Analysis]
214 Trejo Gabriel y Galán J. Stroke as a complication and prognostic factor of COVID-19. Neurología (English Edition) 2020;35:318-22. [DOI: 10.1016/j.nrleng.2020.04.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 1] [Article Influence: 6.5] [Reference Citation Analysis]
215 Viola P, Ralli M, Pisani D, Malanga D, Sculco D, Messina L, Laria C, Aragona T, Leopardi G, Ursini F, Scarpa A, Topazio D, Cama A, Vespertini V, Quintieri F, Cosco L, Cunsolo EM, Chiarella G. Tinnitus and equilibrium disorders in COVID-19 patients: preliminary results. Eur Arch Otorhinolaryngol 2021;278:3725-30. [PMID: 33095432 DOI: 10.1007/s00405-020-06440-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
216 Barón-Sánchez J, Santiago C, Goizueta-San Martín G, Arca R, Fernández R. Smell and taste disorders in Spanish patients with mild COVID-19. Neurologia (Engl Ed) 2020;35:633-8. [PMID: 32900532 DOI: 10.1016/j.nrl.2020.07.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
217 Champion SN, Williams IM, Lage MM, Stagner AM. Pathology of the Brain and the Eye in Severe Acute Respiratory Syndrome Coronavirus-2-Infected Patients: A Review. J Neuroophthalmol 2021;41:285-92. [PMID: 33935221 DOI: 10.1097/WNO.0000000000001275] [Reference Citation Analysis]
218 Wang Z, Yang Y, Liang X, Gao B, Liu M, Li W, Chen Z, Wang Z. COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management. Front Neurol 2020;11:571996. [PMID: 33193019 DOI: 10.3389/fneur.2020.571996] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
219 Cárdenas G, Fragoso G, Sciutto E. Neuroinflammation in SARS-CoV2 infection: Pathogenesis and clinical manifestations. Current Opinion in Pharmacology 2021. [DOI: 10.1016/j.coph.2021.12.008] [Reference Citation Analysis]
220 Kaliyaperumal D, Rk K, Alagesan M, Ramalingam S. Characterization of cardiac autonomic function in COVID-19 using heart rate variability: a hospital based preliminary observational study. J Basic Clin Physiol Pharmacol 2021;32:247-53. [PMID: 33705614 DOI: 10.1515/jbcpp-2020-0378] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
221 Veleri S. Neurotropism of SARS-CoV-2 and neurological diseases of the central nervous system in COVID-19 patients. Exp Brain Res 2021. [PMID: 34694467 DOI: 10.1007/s00221-021-06244-z] [Reference Citation Analysis]
222 Meppiel E, Peiffer-Smadja N, Maury A, Bekri I, Delorme C, Desestret V, Gorza L, Hautecloque-Raysz G, Landre S, Lannuzel A, Moulin S, Perrin P, Petitgas P, SellaI F, Wang A, Tattevin P, de Broucker T; contributors to the NeuroCOVID registry. Neurologic manifestations associated with COVID-19: a multicentre registry. Clin Microbiol Infect 2021;27:458-66. [PMID: 33189873 DOI: 10.1016/j.cmi.2020.11.005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
223 Latreille E, Lee WL. Interactions of Influenza and SARS-CoV-2 with the Lung Endothelium: Similarities, Differences, and Implications for Therapy. Viruses. 2021;13. [PMID: 33499234 DOI: 10.3390/v13020161] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
224 Rahmawati PL, Tini K, Susilawathi NM, Wijayanti IAS, Samatra DP. Pathomechanism and Management of Stroke in COVID-19: Review of Immunopathogenesis, Coagulopathy, Endothelial Dysfunction, and Downregulation of ACE2. J Clin Neurol 2021;17:155-63. [PMID: 33835735 DOI: 10.3988/jcn.2021.17.2.155] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
225 Rodríguez-Alfonso B, Ruiz Solís S, Silva-Hernández L, Pintos Pascual I, Aguado Ibáñez S, Salas Antón C. 18F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae. Rev Esp Med Nucl Imagen Mol 2021;40:299-309. [PMID: 34312108 DOI: 10.1016/j.remn.2021.07.002] [Reference Citation Analysis]
226 Haidar MA, Jourdi H, Haj Hassan Z, Ashekyan O, Fardoun M, Wehbe Z, Maaliki D, Wehbe M, Mondello S, Abdelhady S, Shahjouei S, Bizri M, Mechref Y, Gold MS, Dbaibo G, Zaraket H, Eid AH, Kobeissy F. Neurological and Neuropsychological Changes Associated with SARS-CoV-2 Infection: New Observations, New Mechanisms. Neuroscientist 2021;:1073858420984106. [PMID: 33393420 DOI: 10.1177/1073858420984106] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 8.0] [Reference Citation Analysis]
227 Bullock HA, Goldsmith CS, Miller SE. Best practices for correctly identifying coronavirus by transmission electron microscopy. Kidney Int 2021;99:824-7. [PMID: 33493525 DOI: 10.1016/j.kint.2021.01.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
228 Dowd E, McKernan DP. Back to the future: lessons from past viral infections and the link with Parkinson's disease. Neuronal Signal 2021;5:NS20200051. [PMID: 33953960 DOI: 10.1042/NS20200051] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
229 Saitta L, Molin A, Villani F, Insorsi A, Roccatagliata L, Inglese M, Bassetti M, Pelosi P, Castellan L, Gerevini S, Robba C, Patroniti N. Brain microvascular occlusive disorder in COVID-19: a case report. Neurol Sci 2020;41:3401-4. [PMID: 33034804 DOI: 10.1007/s10072-020-04795-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
230 Freij BJ, Gebara BM, Tariq R, Wang AM, Gibson J, El-Wiher N, Krasan G, Patek PM, Levasseur KA, Amin M, Fullmer JM. Fatal central nervous system co-infection with SARS-CoV-2 and tuberculosis in a healthy child. BMC Pediatr 2020;20:429. [PMID: 32907595 DOI: 10.1186/s12887-020-02308-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
231 Kasal DA, De Lorenzo A, Tibiriçá E. COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System. Heart Lung Circ 2020;29:1596-602. [PMID: 32972810 DOI: 10.1016/j.hlc.2020.08.010] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
232 Bulfamante G, Chiumello D, Canevini MP, Priori A, Mazzanti M, Centanni S, Felisati G. First ultrastructural autoptic findings of SARS -Cov-2 in olfactory pathways and brainstem. Minerva Anestesiol 2020;86. [DOI: 10.23736/s0375-9393.20.14772-2] [Cited by in Crossref: 42] [Cited by in F6Publishing: 27] [Article Influence: 21.0] [Reference Citation Analysis]
233 Oktar AÇ, Göçgün N, Yaşgüçlükal MA, Bayar MD, Alaçam S, Karabulut N, Duman EB, Şişman B, Baştan B, Balcı BP, Çokar Ö. COVID-19-associated Isolated Cortical Vein Thrombosis: Detection of SARS‐CoV‐2 in CSF. The Neurohospitalist. [DOI: 10.1177/19418744221079145] [Reference Citation Analysis]
234 Barrantes FJ. The unfolding palette of COVID-19 multisystemic syndrome and its neurological manifestations. Brain Behav Immun Health 2021;14:100251. [PMID: 33842898 DOI: 10.1016/j.bbih.2021.100251] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
235 de Melo BAG, Mundim MV, Lemes RMR, Cruz EM, Ribeiro TN, Santiago CF, da Fonsêca JHL, Benincasa JC, Stilhano RS, Mantovani N, Santana LC, Durães-Carvalho R, Diaz RS, Janini LMR, Maricato JT, Porcionatto MA. 3D Bioprinted Neural-Like Tissue as a Platform to Study Neurotropism of Mouse-Adapted SARS-CoV-2. Adv Biol (Weinh) 2022;:e2200002. [PMID: 35521969 DOI: 10.1002/adbi.202200002] [Reference Citation Analysis]
236 Santonja C, Heras F, Núñez L, Requena L. COVID-19 chilblain-like lesion: immunohistochemical demonstration of SARS-CoV-2 spike protein in blood vessel endothelium and sweat gland epithelium in a polymerase chain reaction-negative patient. Br J Dermatol 2020;183:778-80. [PMID: 32585767 DOI: 10.1111/bjd.19338] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 12.5] [Reference Citation Analysis]
237 McGuone D, Sinard J, Gill JR, Masters A, Liu C, Morotti R, Parkash V. Autopsy Services and Emergency Preparedness of a Tertiary Academic Hospital Mortuary for the COVID-19 Public Health Emergency: The Yale Plan. Adv Anat Pathol 2020;27:355-62. [PMID: 32649315 DOI: 10.1097/PAP.0000000000000274] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
238 Moccia F, Negri S, Faris P, Perna A, De Luca A, Soda T, Berra-Romani R, Guerra G. Targeting Endolysosomal Two-Pore Channels to Treat Cardiovascular Disorders in the Novel COronaVIrus Disease 2019. Front Physiol 2021;12:629119. [PMID: 33574769 DOI: 10.3389/fphys.2021.629119] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
239 Swain O, Romano SK, Miryala R, Tsai J, Parikh V, Umanah GKE. SARS-CoV-2 Neuronal Invasion and Complications: Potential Mechanisms and Therapeutic Approaches. J Neurosci 2021;41:5338-49. [PMID: 34162747 DOI: 10.1523/JNEUROSCI.3188-20.2021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
240 Flores G. SARS-COV-2 (COVID-19) has neurotropic and neuroinvasive properties. Int J Clin Pract 2021;75:e13708. [PMID: 32935417 DOI: 10.1111/ijcp.13708] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
241 Thomas A, Hiremath S, Baju M. Novel Presentation of Pediatric Inflammatory Multisystem Syndrome Temporally Associated with COVID-19. Journal of Pediatric Neurology. [DOI: 10.1055/s-0041-1725982] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
242 Sanclemente-Alaman I, Moreno-Jiménez L, Benito-Martín MS, Canales-Aguirre A, Matías-Guiu JA, Matías-Guiu J, Gómez-Pinedo U. Experimental Models for the Study of Central Nervous System Infection by SARS-CoV-2. Front Immunol 2020;11:2163. [PMID: 32983181 DOI: 10.3389/fimmu.2020.02163] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
243 Hosseini AA, Shetty AK, Sprigg N, Auer DP, Constantinescu CS. Delirium as a presenting feature in COVID-19: Neuroinvasive infection or autoimmune encephalopathy? Brain Behav Immun 2020;88:68-70. [PMID: 32531427 DOI: 10.1016/j.bbi.2020.06.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 14.0] [Reference Citation Analysis]
244 Tiwari L, Shekhar S, Bansal A, Kumar S. COVID-19 associated arterial ischaemic stroke and multisystem inflammatory syndrome in children: a case report. Lancet Child Adolesc Health 2021;5:88-90. [PMID: 33340468 DOI: 10.1016/S2352-4642(20)30314-X] [Cited by in Crossref: 13] [Cited by in F6Publishing: 5] [Article Influence: 6.5] [Reference Citation Analysis]
245 Yapici-Eser H, Koroglu YE, Oztop-Cakmak O, Keskin O, Gursoy A, Gursoy-Ozdemir Y. Neuropsychiatric Symptoms of COVID-19 Explained by SARS-CoV-2 Proteins' Mimicry of Human Protein Interactions. Front Hum Neurosci 2021;15:656313. [PMID: 33833673 DOI: 10.3389/fnhum.2021.656313] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
246 Almazroa A, Alamri S, Alabdulkader B, Alkozi H, Khan A, Alghamdi W. Ocular transmission and manifestation for coronavirus disease: a systematic review. Int Health 2021:ihab028. [PMID: 34043796 DOI: 10.1093/inthealth/ihab028] [Reference Citation Analysis]
247 Borah P, Deb PK, Chandrasekaran B, Goyal M, Bansal M, Hussain S, Shinu P, Venugopala KN, Al-Shar'i NA, Deka S, Singh V. Neurological Consequences of SARS-CoV-2 Infection and Concurrence of Treatment-Induced Neuropsychiatric Adverse Events in COVID-19 Patients: Navigating the Uncharted. Front Mol Biosci 2021;8:627723. [PMID: 33681293 DOI: 10.3389/fmolb.2021.627723] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
248 Clough E, Chean KT, Inigo J, Tubbesing KE, Chandra D, Chaves L, Reynolds JL, Aalinkeel R, Schwartz SA, Khmaladze A, Mahajan SD. Mitochondrial Dynamics in SARS-COV2 Spike Protein Treated Human Microglia: Implications for Neuro-COVID. J Neuroimmune Pharmacol 2021. [PMID: 34599743 DOI: 10.1007/s11481-021-10015-6] [Reference Citation Analysis]
249 Rodríguez-Alfonso B, Ruiz Solís S, Silva-Hernández L, Pintos Pascual I, Aguado Ibáñez S, Salas Antón C. 18F-FDG-PET/CT in SARS-CoV-2 infection and its sequelae. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2021;40:299-309. [PMID: 34340958 DOI: 10.1016/j.remnie.2021.07.005] [Reference Citation Analysis]
250 Zhang L, Zhou L, Bao L, Liu J, Zhu H, Lv Q, Liu R, Chen W, Tong W, Wei Q, Xu Y, Deng W, Gao H, Xue J, Song Z, Yu P, Han Y, Zhang Y, Sun X, Yu X, Qin C. SARS-CoV-2 crosses the blood-brain barrier accompanied with basement membrane disruption without tight junctions alteration. Signal Transduct Target Ther 2021;6:337. [PMID: 34489403 DOI: 10.1038/s41392-021-00719-9] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
251 Byrnes S, Bisen M, Syed B, Huda S, Siddique Z, Sampat P, Russo R, Oueida Z, Johri G, Dargon I. COVID-19 encephalopathy masquerading as substance withdrawal. J Med Virol 2020;92:2376-8. [PMID: 32458578 DOI: 10.1002/jmv.26065] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
252 Li YC, Zhang Y, Tan BH. What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2. J Med Virol 2021;93:4247-57. [PMID: 33724490 DOI: 10.1002/jmv.26943] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
253 Keng A, Brown EE, Rostas A, Rajji TK, Pollock BG, Mulsant BH, Kumar S. Effectively Caring for Individuals With Behavioral and Psychological Symptoms of Dementia During the COVID-19 Pandemic. Front Psychiatry 2020;11:573367. [PMID: 33132936 DOI: 10.3389/fpsyt.2020.573367] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
254 Xydakis MS, Albers MW, Holbrook EH, Lyon DM, Shih RY, Frasnelli JA, Pagenstecher A, Kupke A, Enquist LW, Perlman S. Post-viral effects of COVID-19 in the olfactory system and their implications. Lancet Neurol 2021;20:753-61. [PMID: 34339626 DOI: 10.1016/S1474-4422(21)00182-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
255 Khatoon F, Prasad K, Kumar V. COVID-19 associated nervous system manifestations. Sleep Med 2021:S1389-9457(21)00387-7. [PMID: 34321155 DOI: 10.1016/j.sleep.2021.07.005] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
256 May Fulton C, Bailey WJ. Live Viral Vaccine Neurovirulence Screening: Current and Future Models. Vaccines (Basel) 2021;9:710. [PMID: 34209433 DOI: 10.3390/vaccines9070710] [Reference Citation Analysis]
257 Bidram E, Esmaeili Y, Amini A, Sartorius R, Tay FR, Shariati L, Makvandi P. Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside. ACS Biomater Sci Eng 2021;7:2150-76. [PMID: 33979143 DOI: 10.1021/acsbiomaterials.1c00318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
258 Blackburn KM, Wang C. Post-infectious neurological disorders. Ther Adv Neurol Disord 2020;13:1756286420952901. [PMID: 32944082 DOI: 10.1177/1756286420952901] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
259 Prakash A, Singh H, Sarma P, Bhattacharyya A, Dhibar DP, Balaini N, Shree R, Goyal M, Modi M, Medhi B. nCoV-2019 infection induced neurological outcome and manifestation, linking its historical ancestor SARS-CoV and MERS-CoV: a systematic review and meta-analysis. Sci Rep 2021;11:12888. [PMID: 34145351 DOI: 10.1038/s41598-021-92188-x] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
260 Zimmer A, Youngblood A, Adnane A, Miller BJ, Goldsmith DR. Prenatal exposure to viral infection and neuropsychiatric disorders in offspring: A review of the literature and recommendations for the COVID-19 pandemic. Brain Behav Immun 2021;91:756-70. [PMID: 33152446 DOI: 10.1016/j.bbi.2020.10.024] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
261 Semyachkina-Glushkovskaya O, Mamedova A, Vinnik V, Klimova M, Saranceva E, Ageev V, Yu T, Zhu D, Penzel T, Kurths J. Brain Mechanisms of COVID-19-Sleep Disorders. Int J Mol Sci 2021;22:6917. [PMID: 34203143 DOI: 10.3390/ijms22136917] [Reference Citation Analysis]
262 Zamani R, Pouremamali R, Rezaei N. Central neuroinflammation in Covid-19: a systematic review of 182 cases with encephalitis, acute disseminated encephalomyelitis, and necrotizing encephalopathies. Rev Neurosci 2021. [PMID: 34536341 DOI: 10.1515/revneuro-2021-0082] [Reference Citation Analysis]
263 Ning Q, Wu D, Wang X, Xi D, Chen T, Chen G, Wang H, Lu H, Wang M, Zhu L, Hu J, Liu T, Ma K, Han M, Luo X. The mechanism underlying extrapulmonary complications of the coronavirus disease 2019 and its therapeutic implication. Signal Transduct Target Ther 2022;7:57. [PMID: 35197452 DOI: 10.1038/s41392-022-00907-1] [Reference Citation Analysis]
264 Zito Marino F, De Cristofaro T, Varriale M, Zannini G, Ronchi A, La Mantia E, Campobasso CP, De Micco F, Mascolo P, Municinò M, Municinò E, Vestini F, Pinto O, Moccia M, De Stefano N, Nappi O, Sementa C, Zotti G, Pianese L, Giordano C, Franco R. Variable levels of spike and ORF1ab RNA in post-mortem lung samples of SARS-CoV-2-positive subjects: comparison between ISH and RT-PCR. Virchows Arch 2022. [PMID: 35103846 DOI: 10.1007/s00428-021-03262-8] [Reference Citation Analysis]
265 Vijiala S, Epiney JB, Jöhr J, Pincherle A, Meyer MM, Du Pasquier R, Prior JO, Diserens K. Case Report: Behavioral Unresponsiveness in Acute COVID-19 Patients: The Utility of the Motor Behavior Tool-Revised and 18F-FDG PET/CT. Front Neurol 2021;12:644848. [PMID: 33995248 DOI: 10.3389/fneur.2021.644848] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
266 Nia AM, Srinivasan VM, Hayworth MK, Lall RR, Kan P. A History of Cerebrovascular Disease Is Independently Associated with Increased Morbidity and Mortality in Patients with COVID-19: A Cohort Study of 369,563 COVID-19 Cases in the USA. Cerebrovasc Dis 2021;:1-9. [PMID: 34515073 DOI: 10.1159/000517499] [Reference Citation Analysis]
267 Jha NK, Ojha S, Jha SK, Dureja H, Singh SK, Shukla SD, Chellappan DK, Gupta G, Bhardwaj S, Kumar N, Jeyaraman M, Jain R, Muthu S, Kar R, Kumar D, Goswami VK, Ruokolainen J, Kesari KK, Singh SK, Dua K. Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations. J Mol Neurosci 2021;71:2192-209. [PMID: 33464535 DOI: 10.1007/s12031-020-01767-6] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 21.0] [Reference Citation Analysis]
268 Majumdar R, Vrana JA, Koepplin JW, Milosevic D, Roden AC, Garcia JJ, Kipp BR, Moyer AM. SARS-CoV-2 RNA Detection in Formalin-Fixed Paraffin-Embedded (FFPE) Tissue by Droplet Digital PCR (ddPCR). Clin Chim Acta 2022:S0009-8981(22)01141-X. [PMID: 35550815 DOI: 10.1016/j.cca.2022.05.007] [Reference Citation Analysis]
269 Abboud H, Abboud FZ, Kharbouch H, Arkha Y, El Abbadi N, El Ouahabi A. COVID-19 and SARS-Cov-2 Infection: Pathophysiology and Clinical Effects on the Nervous System. World Neurosurg 2020;140:49-53. [PMID: 32474093 DOI: 10.1016/j.wneu.2020.05.193] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 20.5] [Reference Citation Analysis]
270 Finsterer J, Scorza FA. Infectious/parainfectious, nonvascular, nonhypoxic central nervous system disease in 48 COVID-19 patients. J Med Virol 2021;93:626-30. [PMID: 32761914 DOI: 10.1002/jmv.26399] [Reference Citation Analysis]
271 Butowt R, von Bartheld CS. Anosmia in COVID-19: Underlying Mechanisms and Assessment of an Olfactory Route to Brain Infection. Neuroscientist 2020;:1073858420956905. [PMID: 32914699 DOI: 10.1177/1073858420956905] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 28.5] [Reference Citation Analysis]
272 Simonson TS, Baker TL, Banzett RB, Bishop T, Dempsey JA, Feldman JL, Guyenet PG, Hodson EJ, Mitchell GS, Moya EA, Nokes BT, Orr JE, Owens RL, Poulin M, Rawling JM, Schmickl CN, Watters JJ, Younes M, Malhotra A. Silent hypoxaemia in COVID-19 patients. J Physiol 2021;599:1057-65. [PMID: 33347610 DOI: 10.1113/JP280769] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 12.0] [Reference Citation Analysis]
273 Callan C, Ladds E, Husain L, Pattinson K, Greenhalgh T. 'I can't cope with multiple inputs': a qualitative study of the lived experience of 'brain fog' after COVID-19. BMJ Open 2022;12:e056366. [PMID: 35149572 DOI: 10.1136/bmjopen-2021-056366] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
274 Domingues R, Lippi A, Setz C, Outeiro TF, Krisko A. SARS-CoV-2, immunosenescence and inflammaging: partners in the COVID-19 crime. Aging (Albany NY) 2020;12:18778-89. [PMID: 32991323 DOI: 10.18632/aging.103989] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
275 Peluso MJ, Hellmuth J, Chow FC. Central Nervous System Effects of COVID-19 in People with HIV Infection. Curr HIV/AIDS Rep 2021;18:538-48. [PMID: 34843065 DOI: 10.1007/s11904-021-00582-x] [Reference Citation Analysis]
276 Miners S, Kehoe PG, Love S. Cognitive impact of COVID-19: looking beyond the short term. Alzheimers Res Ther 2020;12:170. [PMID: 33380345 DOI: 10.1186/s13195-020-00744-w] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 10.5] [Reference Citation Analysis]
277 Krey L, Huber MK, Höglinger GU, Wegner F. Can SARS-CoV-2 Infection Lead to Neurodegeneration and Parkinson's Disease? Brain Sci 2021;11:1654. [PMID: 34942956 DOI: 10.3390/brainsci11121654] [Reference Citation Analysis]
278 Schober ME, Pavia AT, Bohnsack JF. Neurologic Manifestations of COVID-19 in Children: Emerging Pathophysiologic Insights. Pediatr Crit Care Med 2021;22:655-61. [PMID: 33965992 DOI: 10.1097/PCC.0000000000002774] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
279 Moonis G, Filippi CG, Kirsch CFE, Mohan S, Stein EG, Hirsch JA, Mahajan A. The Spectrum of Neuroimaging Findings on CT and MRI in Adults With COVID-19. American Journal of Roentgenology 2021;217:959-74. [DOI: 10.2214/ajr.20.24839] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
280 Østergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiol Rep 2021;9:e14726. [PMID: 33523608 DOI: 10.14814/phy2.14726] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
281 Mingoti MED, Bertollo AG, Simões JLB, Francisco GR, Bagatini MD, Ignácio ZM. COVID-19, Oxidative Stress, and Neuroinflammation in the Depression Route. J Mol Neurosci 2022. [PMID: 35322375 DOI: 10.1007/s12031-022-02004-y] [Reference Citation Analysis]
282 Tarnawski AS, Ahluwalia A. Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs. World J Gastroenterol 2022;28:275-89. [PMID: 35110950 DOI: 10.3748/wjg.v28.i3.275] [Reference Citation Analysis]
283 Lakshan Raj S, Vasanthi T, Baineni R, Sivabalan S. Neurological Manifestations of COVID-19 in Children. Indian Pediatr 2020;57:1185-6. [DOI: 10.1007/s13312-020-2079-0] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
284 Ogier M, Andéol G, Sagui E, Dal Bo G. How to detect and track chronic neurologic sequelae of COVID-19? Use of auditory brainstem responses and neuroimaging for long-term patient follow-up. Brain Behav Immun Health 2020;5:100081. [PMID: 32427134 DOI: 10.1016/j.bbih.2020.100081] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 10.0] [Reference Citation Analysis]
285 Aghayari Sheikh Neshin S, Shahjouei S, Koza E, Friedenberg I, Khodadadi F, Sabra M, Kobeissy F, Ansari S, Tsivgoulis G, Li J, Abedi V, Wolk DM, Zand R. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front Cardiovasc Med 2021;8:649922. [PMID: 33855053 DOI: 10.3389/fcvm.2021.649922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
286 Sanchez-Larsen A, Gonzalez-Villar E, Díaz-Maroto I, Layos-Romero A, Martínez-Martín Á, Alcahut-Rodriguez C, Grande-Martin A, Sopelana-Garay D. Influence of the COVID-19 outbreak in people with epilepsy: Analysis of a Spanish population (EPICOVID registry). Epilepsy Behav 2020;112:107396. [PMID: 32911299 DOI: 10.1016/j.yebeh.2020.107396] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
287 Scoppettuolo P, Borrelli S, Naeije G. Neurological involvement in SARS-CoV-2 infection: A clinical systematic review. Brain Behav Immun Health 2020;5:100094. [PMID: 33521692 DOI: 10.1016/j.bbih.2020.100094] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 6.5] [Reference Citation Analysis]
288 Shang YF, Liu T, Yu JN, Xu XR, Zahid KR, Wei YC, Wang XH, Zhou FL. Half-year follow-up of patients recovering from severe COVID-19: Analysis of symptoms and their risk factors. J Intern Med 2021;290:444-50. [PMID: 33904618 DOI: 10.1111/joim.13284] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
289 Mukerji SS, Solomon IH. What can we learn from brain autopsies in COVID-19? Neurosci Lett 2021;742:135528. [PMID: 33248159 DOI: 10.1016/j.neulet.2020.135528] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 10.0] [Reference Citation Analysis]
290 Magro CM, Mulvey J, Kubiak J, Mikhail S, Suster D, Crowson AN, Laurence J, Nuovo G. Severe COVID-19: A multifaceted viral vasculopathy syndrome. Ann Diagn Pathol 2021;50:151645. [PMID: 33248385 DOI: 10.1016/j.anndiagpath.2020.151645] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
291 Tizenberg BN, Brenner LA, Lowry CA, Okusaga OO, Benavides DR, Hoisington AJ, Benros ME, Stiller JW, Kessler RC, Postolache TT. Biological and Psychological Factors Determining Neuropsychiatric Outcomes in COVID-19. Curr Psychiatry Rep 2021;23:68. [PMID: 34648081 DOI: 10.1007/s11920-021-01275-3] [Reference Citation Analysis]
292 Finsterer J, Stollberger C. Update on the neurology of COVID-19. J Med Virol 2020;92:2316-8. [PMID: 32401352 DOI: 10.1002/jmv.26000] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
293 Alquisiras-Burgos I, Peralta-Arrieta I, Alonso-Palomares LA, Zacapala-Gómez AE, Salmerón-Bárcenas EG, Aguilera P. Neurological Complications Associated with the Blood-Brain Barrier Damage Induced by the Inflammatory Response During SARS-CoV-2 Infection. Mol Neurobiol 2021;58:520-35. [PMID: 32978729 DOI: 10.1007/s12035-020-02134-7] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
294 Wan D, Du T, Hong W, Chen L, Que H, Lu S, Peng X. Neurological complications and infection mechanism of SARS-COV-2. Signal Transduct Target Ther 2021;6:406. [PMID: 34815399 DOI: 10.1038/s41392-021-00818-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
295 Ahmed AK, Sayad R, Mahmoud IA, El-monem AMA, Badry SH, Ibrahim IH, Hafez MH, El-mokhtar MA, Sayed IM. “Anosmia” the mysterious collateral damage of COVID-19. J Neurovirol . [DOI: 10.1007/s13365-022-01060-9] [Reference Citation Analysis]
296 Inaba H, Aizawa T. Coronavirus Disease 2019 and the Thyroid - Progress and Perspectives. Front Endocrinol (Lausanne) 2021;12:708333. [PMID: 34276567 DOI: 10.3389/fendo.2021.708333] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
297 Pincherle A, Jöhr J, Pancini L, Leocani L, Dalla Vecchia L, Ryvlin P, Schiff ND, Diserens K. Intensive Care Admission and Early Neuro-Rehabilitation. Lessons for COVID-19? Front Neurol 2020;11:880. [PMID: 32982916 DOI: 10.3389/fneur.2020.00880] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
298 Xu Y, Zhuang Y, Kang L. A Review of Neurological Involvement in Patients with SARS-CoV-2 Infection. Med Sci Monit 2021;27:e932962. [PMID: 34145211 DOI: 10.12659/MSM.932962] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
299 Song J, Lu C, Leszek J, Zhang J. Design and Development of Nanomaterial-Based Drug Carriers to Overcome the Blood-Brain Barrier by Using Different Transport Mechanisms. Int J Mol Sci 2021;22:10118. [PMID: 34576281 DOI: 10.3390/ijms221810118] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
300 Jardim Vaz de Mello L, Guimaraes Silva E, Oliveira Correa Rabelo G, Evaristo Leite M, Vieira NR, Bahadori M, Seifi A, Godoy DA. Neurologic Compromise in COVID-19: A Literature Review. J Neurol Res 2020;10:164-72. [PMID: 33984100 DOI: 10.14740/jnr619] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
301 Eskandar EN, Altschul DJ, de la Garza Ramos R, Cezayirli P, Unda SR, Benton J, Dardick J, Toma A, Patel N, Malaviya A, Flomenbaum D, Fernandez-Torres J, Lu J, Holland R, Burchi E, Zampolin R, Hsu K, McClelland A, Burns J, Erdfarb A, Malhotra R, Gong M, Semczuk P, Gursky J, Ferastraoaru V, Rosengard J, Antoniello D, Labovitz D, Esenwa C, Milstein M, Boro A, Mehler MF. Neurologic Syndromes Predict Higher In-Hospital Mortality in COVID-19. Neurology. 2021;96:e1527-e1538. [PMID: 33443111 DOI: 10.1212/wnl.0000000000011356] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
302 Wang C, Zhang M, Garcia G Jr, Tian E, Cui Q, Chen X, Sun G, Wang J, Arumugaswami V, Shi Y. ApoE-Isoform-Dependent SARS-CoV-2 Neurotropism and Cellular Response. Cell Stem Cell 2021;28:331-342.e5. [PMID: 33450186 DOI: 10.1016/j.stem.2020.12.018] [Cited by in Crossref: 27] [Cited by in F6Publishing: 31] [Article Influence: 27.0] [Reference Citation Analysis]
303 Khan A, Khan T, Ali S, Aftab S, Wang Y, Qiankun W, Khan M, Suleman M, Ali S, Heng W, Ali SS, Wei DQ, Mohammad A. SARS-CoV-2 new variants: Characteristic features and impact on the efficacy of different vaccines. Biomed Pharmacother 2021;143:112176. [PMID: 34562770 DOI: 10.1016/j.biopha.2021.112176] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
304 Jensen MP, Le Quesne J, Officer-Jones L, Teodòsio A, Thaventhiran J, Ficken C, Goddard M, Smith C, Menon D, Allinson KSJ. Neuropathological findings in two patients with fatal COVID-19. Neuropathol Appl Neurobiol 2021;47:17-25. [PMID: 32895961 DOI: 10.1111/nan.12662] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
305 Sansone P, Giaccari LG, Aurilio C, Coppolino F, Esposito V, Fiore M, Paladini A, Passavanti MB, Pota V, Pace MC. Post-Infectious Guillain-Barré Syndrome Related to SARS-CoV-2 Infection: A Systematic Review. Life (Basel) 2021;11:167. [PMID: 33670000 DOI: 10.3390/life11020167] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
306 Whitmore HAB, Kim LA. Understanding the Role of Blood Vessels in the Neurologic Manifestations of Coronavirus Disease 2019 (COVID-19). Am J Pathol 2021:S0002-9440(21)00260-1. [PMID: 34126084 DOI: 10.1016/j.ajpath.2021.04.017] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
307 Kothandaraman N, Rengaraj A, Xue B, Yew WS, Velan SS, Karnani N, Leow MKS. COVID-19 endocrinopathy with hindsight from SARS. Am J Physiol Endocrinol Metab 2021;320:E139-50. [PMID: 33236920 DOI: 10.1152/ajpendo.00480.2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
308 Faber I, Brandão PRP, Menegatti F, de Carvalho Bispo DD, Maluf FB, Cardoso F. Coronavirus Disease 2019 and Parkinsonism: A Non-post-encephalitic Case. Mov Disord 2020;35:1721-2. [PMID: 32815213 DOI: 10.1002/mds.28277] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 16.0] [Reference Citation Analysis]
309 Fifi JT, Mocco J. COVID-19 related stroke in young individuals. Lancet Neurol 2020;19:713-5. [PMID: 32822622 DOI: 10.1016/S1474-4422(20)30272-6] [Cited by in Crossref: 49] [Cited by in F6Publishing: 33] [Article Influence: 24.5] [Reference Citation Analysis]
310 Puccioni-Sohler M, Poton AR, Franklin M, Silva SJD, Brindeiro R, Tanuri A. Current evidence of neurological features, diagnosis, and neuropathogenesis associated with COVID-19. Rev Soc Bras Med Trop 2020;53:e20200477. [PMID: 33027418 DOI: 10.1590/0037-8682-0477-2020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
311 Gavriilaki E, Anyfanti P, Gavriilaki M, Lazaridis A, Douma S, Gkaliagkousi E. Endothelial Dysfunction in COVID-19: Lessons Learned from Coronaviruses. Curr Hypertens Rep 2020;22:63. [PMID: 32852642 DOI: 10.1007/s11906-020-01078-6] [Cited by in Crossref: 42] [Cited by in F6Publishing: 33] [Article Influence: 21.0] [Reference Citation Analysis]
312 Buzhdygan TP, DeOre BJ, Baldwin-Leclair A, McGary H, Razmpour R, Galie PA, Potula R, Andrews AM, Ramirez SH. The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in vitro models of the human blood-brain barrier. bioRxiv 2020:2020. [PMID: 32587958 DOI: 10.1101/2020.06.15.150912] [Cited by in Crossref: 18] [Cited by in F6Publishing: 1] [Article Influence: 9.0] [Reference Citation Analysis]
313 Sattar SBA, Haider MA, Zia Z, Niazi M, Iqbal QZ. Clinical, Radiological, and Molecular Findings of Acute Encephalitis in a COVID-19 Patient: A Rare Case Report. Cureus 2020;12:e10650. [PMID: 33133820 DOI: 10.7759/cureus.10650] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
314 Panda PK, Sharawat IK, Panda P, Natarajan V, Bhakat R, Dawman L. Neurological Complications of SARS-CoV-2 Infection in Children: A Systematic Review and Meta-Analysis. J Trop Pediatr 2021;67:fmaa070. [PMID: 32910826 DOI: 10.1093/tropej/fmaa070] [Cited by in Crossref: 13] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
315 Durrani M, Kucharski K, Smith Z, Fien S. Acute Transverse Myelitis Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): A Case Report. Clin Pract Cases Emerg Med 2020;4:344-8. [PMID: 32926682 DOI: 10.5811/cpcem.2020.6.48462] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
316 Becker RC. Autonomic dysfunction in SARS-COV-2 infection acute and long-term implications COVID-19 editor's page series. J Thromb Thrombolysis 2021. [PMID: 34403043 DOI: 10.1007/s11239-021-02549-6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
317 Luft T, Wendtner CM, Kosely F, Radujkovic A, Benner A, Korell F, Kihm L, Bauer MF, Dreger P, Merle U. EASIX for Prediction of Outcome in Hospitalized SARS-CoV-2 Infected Patients. Front Immunol 2021;12:634416. [PMID: 34248931 DOI: 10.3389/fimmu.2021.634416] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
318 Fabbri VP, Riefolo M, Lazzarotto T, Gabrielli L, Cenacchi G, Gallo C, Aspide R, Frascaroli G, Liguori R, Lodi R, Tonon C, D’errico A, Foschini MP. COVID-19 and the Brain: The Neuropathological Italian Experience on 33 Adult Autopsies. Biomolecules 2022;12:629. [DOI: 10.3390/biom12050629] [Reference Citation Analysis]
319 Dewanjee S, Vallamkondu J, Kalra RS, Puvvada N, Kandimalla R, Reddy PH. Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic. Mol Neurobiol 2021. [PMID: 34169443 DOI: 10.1007/s12035-021-02450-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
320 Devlin H, Soltani P. COVID-19 and Dentistry. Encyclopedia 2021;1:496-504. [DOI: 10.3390/encyclopedia1020041] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
321 Sulzer D, Antonini A, Leta V, Nordvig A, Smeyne RJ, Goldman JE, Al-Dalahmah O, Zecca L, Sette A, Bubacco L, Meucci O, Moro E, Harms AS, Xu Y, Fahn S, Ray Chaudhuri K. COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. NPJ Parkinsons Dis 2020;6:18. [PMID: 32885037 DOI: 10.1038/s41531-020-00123-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
322 White-Dzuro G, Gibson LE, Zazzeron L, White-Dzuro C, Sullivan Z, Diiorio DA, Low SA, Chang MG, Bittner EA. Multisystem effects of COVID-19: a concise review for practitioners. Postgrad Med 2021;133:20-7. [PMID: 32921198 DOI: 10.1080/00325481.2020.1823094] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
323 Maiese A, Manetti AC, Bosetti C, Del Duca F, La Russa R, Frati P, Di Paolo M, Turillazzi E, Fineschi V. SARS-CoV-2 and the brain: A review of the current knowledge on neuropathology in COVID-19. Brain Pathol 2021;:e13013. [PMID: 34390282 DOI: 10.1111/bpa.13013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
324 Henningsen MJ, Khatam-Lashgari A, Olsen KB, Jacobsen C, Brøchner CB, Banner J. Translational deep phenotyping of deaths related to the COVID-19 pandemic: protocol for a prospective observational autopsy study. BMJ Open 2021;11:e049083. [PMID: 34452963 DOI: 10.1136/bmjopen-2021-049083] [Reference Citation Analysis]
325 Virhammar J, Kumlien E, Fällmar D, Frithiof R, Jackmann S, Sköld MK, Kadir M, Frick J, Lindeberg J, Olivero-Reinius H, Ryttlefors M, Cunningham JL, Wikström J, Grabowska A, Bondeson K, Bergquist J, Zetterberg H, Rostami E. Acute necrotizing encephalopathy with SARS-CoV-2 RNA confirmed in cerebrospinal fluid. Neurology 2020;95:445-9. [PMID: 32586897 DOI: 10.1212/WNL.0000000000010250] [Cited by in Crossref: 95] [Cited by in F6Publishing: 60] [Article Influence: 47.5] [Reference Citation Analysis]
326 Vasquez-Bonilla WO, Orozco R, Argueta V, Sierra M, Zambrano LI, Muñoz-Lara F, López-Molina DS, Arteaga-Livias K, Grimes Z, Bryce C, Paniz-Mondolfi A, Rodríguez-Morales AJ. A review of the main histopathological findings in coronavirus disease 2019. Hum Pathol 2020;105:74-83. [PMID: 32750378 DOI: 10.1016/j.humpath.2020.07.023] [Cited by in Crossref: 36] [Cited by in F6Publishing: 33] [Article Influence: 18.0] [Reference Citation Analysis]
327 Toniolo S, Scarioni M, Di Lorenzo F, Hort J, Georges J, Tomic S, Nobili F, Frederiksen KS; Management Group of the EAN Dementia and Cognitive Disorders Scientific Panel. Dementia and COVID-19, a Bidirectional Liaison: Risk Factors, Biomarkers, and Optimal Health Care. J Alzheimers Dis 2021;82:883-98. [PMID: 34092646 DOI: 10.3233/JAD-210335] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
328 DeKosky ST, Kochanek PM, Valadka AB, Clark RSB, Chou SH, Au AK, Horvat C, Jha RM, Mannix R, Wisniewski SR, Wintermark M, Rowell SE, Welch RD, Lewis L, House S, Tanzi RE, Smith DR, Vittor AY, Denslow ND, Davis MD, Glushakova OY, Hayes RL. Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients. J Neurotrauma 2021;38:1-43. [PMID: 33115334 DOI: 10.1089/neu.2020.7332] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
329 Al-Sarraj S, Troakes C, Hanley B, Osborn M, Richardson MP, Hotopf M, Bullmore E, Everall IP. Invited Review: The spectrum of neuropathology in COVID-19. Neuropathol Appl Neurobiol 2021;47:3-16. [PMID: 32935873 DOI: 10.1111/nan.12667] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 16.0] [Reference Citation Analysis]
330 Tancheva L, Petralia MC, Miteva S, Dragomanova S, Solak A, Kalfin R, Lazarova M, Yarkov D, Ciurleo R, Cavalli E, Bramanti A, Nicoletti F. Emerging Neurological and Psychobiological Aspects of COVID-19 Infection. Brain Sci 2020;10:E852. [PMID: 33198412 DOI: 10.3390/brainsci10110852] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
331 Septyaningtrias DE, Susilowati R. Neurological involvement of COVID-19: from neuroinvasion and neuroimmune crosstalk to long-term consequences. Rev Neurosci 2021;32:427-42. [PMID: 33550780 DOI: 10.1515/revneuro-2020-0092] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
332 Forero-Peña DA, Hernandez MM, Mozo Herrera IP, Collado Espinal IB, Páez Paz J, Ferro C, Flora-Noda DM, Maricuto AL, Velásquez VL, Camejo-Avila NA, Sordillo EM, Delgado-Noguera LA, Perez-Garcia LA, Morantes Rodríguez CG, Landaeta ME, Paniz-Mondolfi AE. Remitting neuropsychiatric symptoms in COVID-19 patients: Viral cause or drug effect? J Med Virol 2021. [PMID: 34755347 DOI: 10.1002/jmv.27443] [Reference Citation Analysis]
333 Stratton CW, Tang YW, Lu H. Pathogenesis-directed therapy of 2019 novel coronavirus disease. J Med Virol 2021;93:1320-42. [PMID: 33073355 DOI: 10.1002/jmv.26610] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
334 Carnevale S, Beretta P, Morbini P. Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of COVID-19 patient with diarrhea. J Med Virol 2021;93:61-3. [PMID: 32492199 DOI: 10.1002/jmv.26119] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
335 Jafari Khaljiri H, Jamalkhah M, Amini Harandi A, Pakdaman H, Moradi M, Mowla A. Comprehensive Review on Neuro-COVID-19 Pathophysiology and Clinical Consequences. Neurotox Res 2021;39:1613-29. [PMID: 34169404 DOI: 10.1007/s12640-021-00389-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
336 Buja LM, Wolf DA, Zhao B, Akkanti B, McDonald M, Lelenwa L, Reilly N, Ottaviani G, Elghetany MT, Trujillo DO, Aisenberg GM, Madjid M, Kar B. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19): Report of 3 autopsies from Houston, Texas, and review of autopsy findings from other United States cities. Cardiovasc Pathol 2020;48:107233. [PMID: 32434133 DOI: 10.1016/j.carpath.2020.107233] [Cited by in Crossref: 174] [Cited by in F6Publishing: 160] [Article Influence: 87.0] [Reference Citation Analysis]
337 Fontanella MM, Zanin L, Saraceno G, Panciani PP, Migliorati K, Latronico N, Gasparotti R. Comment about the article "SARS-CoV-2 can induce brain and spine demyelinating lesions," Acta Neurochir (Wien) 2020 Jul;162(7):1491-1494. Acta Neurochir (Wien) 2021;163:331-2. [PMID: 33044674 DOI: 10.1007/s00701-020-04604-2] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
338 Chen Z, Li G. Immune response and blood-brain barrier dysfunction during viral neuroinvasion. Innate Immun 2021;27:109-17. [PMID: 32903111 DOI: 10.1177/1753425920954281] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
339 Beyerstedt S, Casaro EB, Rangel ÉB. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection. Eur J Clin Microbiol Infect Dis 2021;40:905-19. [PMID: 33389262 DOI: 10.1007/s10096-020-04138-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 18.0] [Reference Citation Analysis]
340 Li L, Acioglu C, Heary RF, Elkabes S. Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases. Brain Behav Immun 2021;91:740-55. [PMID: 33039660 DOI: 10.1016/j.bbi.2020.10.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
341 Mowla A, Shakibajahromi B, Shahjouei S, Borhani-Haghighi A, Rahimian N, Baharvahdat H, Naderi S, Khorvash F, Altafi D, Ebrahimzadeh SA, Farahmand G, Vaghefi Far A, Sharma VK, Neshin SAS, Tsivgoulis G, Zand R. Cerebral venous sinus thrombosis associated with SARS-CoV-2; a multinational case series. J Neurol Sci 2020;419:117183. [PMID: 33075595 DOI: 10.1016/j.jns.2020.117183] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 13.5] [Reference Citation Analysis]
342 Matsuishi Y, Mathis BJ, Shimojo N, Subrina J, Okubo N, Inoue Y. Severe COVID-19 Infection Associated with Endothelial Dysfunction Induces Multiple Organ Dysfunction: A Review of Therapeutic Interventions. Biomedicines 2021;9:279. [PMID: 33801921 DOI: 10.3390/biomedicines9030279] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
343 Dickinson PJ. Coronavirus Infection of the Central Nervous System: Animal Models in the Time of COVID-19. Front Vet Sci 2020;7:584673. [PMID: 33195610 DOI: 10.3389/fvets.2020.584673] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
344 Gomez-Pinedo U, Matias-Guiu J, Sanclemente-Alaman I, Moreno-Jimenez L, Montero-Escribano P, Matias-Guiu JA. SARS-CoV-2 as a Potential Trigger of Neurodegenerative Diseases. Mov Disord 2020;35:1104-5. [PMID: 32502296 DOI: 10.1002/mds.28179] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
345 Nejad JH, Allahyari F, Hosseinzadeh R, Heiat M, Ranjbar R. Neurological symptoms of COVID-19 infection; a cross-sectional study on hospitalized COVID-19 patients in Iran. Clin Neurol Neurosurg 2021;210:106985. [PMID: 34700274 DOI: 10.1016/j.clineuro.2021.106985] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
346 Chakraborty S, Basu A. Catching hold of COVID-19-related encephalitis by tracking ANGPTL4 signature in blood: An Editorial Highlight for "Endothelial cell biomarkers in critically ill COVID-19-patients with encephalitis": An Editorial Highlight for "Endothelial cell biomarkers in critically ill COVID-19-patients with encephalitis". J Neurochem 2021. [PMID: 34967002 DOI: 10.1111/jnc.15560] [Reference Citation Analysis]
347 Barón-sánchez J, Santiago C, Goizueta-san Martín G, Arca R, Fernández R. Smell and taste disorders in Spanish patients with mild COVID-19. Neurología (English Edition) 2020;35:633-8. [DOI: 10.1016/j.nrleng.2020.07.007] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
348 Llorens S, Nava E, Muñoz-López M, Sánchez-Larsen Á, Segura T. Neurological Symptoms of COVID-19: The Zonulin Hypothesis. Front Immunol 2021;12:665300. [PMID: 33981312 DOI: 10.3389/fimmu.2021.665300] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
349 Rahman A, Niloofa R, De Zoysa IM, Cooray AD, Kariyawasam J, Seneviratne SL. Neurological manifestations in COVID-19: A narrative review. SAGE Open Med 2020;8:2050312120957925. [PMID: 32974019 DOI: 10.1177/2050312120957925] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
350 Pizzi MA. Acute Neurologic Manifestations of Respiratory Viruses. Continuum (Minneap Minn) 2021;27:1365-81. [PMID: 34618764 DOI: 10.1212/CON.0000000000001007] [Reference Citation Analysis]
351 Bielarz V, Willemart K, Avalosse N, De Swert K, Lotfi R, Lejeune N, Poulain F, Ninanne N, Gilloteaux J, Gillet N, Nicaise C. Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection. Brain Res 2021;1758:147344. [PMID: 33556379 DOI: 10.1016/j.brainres.2021.147344] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
352 Iadecola C, Anrather J, Kamel H. Effects of COVID-19 on the Nervous System. Cell 2020;183:16-27.e1. [PMID: 32882182 DOI: 10.1016/j.cell.2020.08.028] [Cited by in Crossref: 134] [Cited by in F6Publishing: 141] [Article Influence: 67.0] [Reference Citation Analysis]
353 Pouga L. Encephalitic syndrome and anosmia in COVID-19: Do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases. J Med Virol 2021;93:550-8. [PMID: 32672843 DOI: 10.1002/jmv.26309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
354 Fenrich M, Mrdenovic S, Balog M, Tomic S, Zjalic M, Roncevic A, Mandic D, Debeljak Z, Heffer M. SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury. Front Cell Neurosci 2020;14:229. [PMID: 32848621 DOI: 10.3389/fncel.2020.00229] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 13.5] [Reference Citation Analysis]
355 Jiang L, Driedonks TAP, Jong WSP, Dhakal S, Bart van den Berg van Saparoea H, Sitaras I, Zhou R, Caputo C, Littlefield K, Lowman M, Chen M, Lima G, Gololobova O, Smith B, Mahairaki V, Riley Richardson M, Mulka KR, Lane AP, Klein SL, Pekosz A, Brayton C, Mankowski JL, Luirink J, Villano JS, Witwer KW. A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants. J Extracell Vesicles 2022;11:e12192. [PMID: 35289114 DOI: 10.1002/jev2.12192] [Reference Citation Analysis]
356 Oliveira AC, Richards EM, Karas MM, Pepine CJ, Raizada MK. Would Repurposing Minocycline Alleviate Neurologic Manifestations of COVID-19? Front Neurosci 2020;14:577780. [PMID: 33117121 DOI: 10.3389/fnins.2020.577780] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
357 Harapan BN, Yoo HJ. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19). J Neurol 2021;268:3059-71. [PMID: 33486564 DOI: 10.1007/s00415-021-10406-y] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
358 Tsivgoulis G, Palaiodimou L, Zand R, Lioutas VA, Krogias C, Katsanos AH, Shoamanesh A, Sharma VK, Shahjouei S, Baracchini C, Vlachopoulos C, Gournellis R, Sfikakis PP, Sandset EC, Alexandrov AV, Tsiodras S. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord 2020;13:1756286420978004. [PMID: 33343709 DOI: 10.1177/1756286420978004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
359 Giri R, Kumar A, Saini M, Sharma RK. Living with the virus: Infection and epidemiology of COVID-19 in hotspot area of India. J Public Aff 2021;:e2651. [PMID: 33786027 DOI: 10.1002/pa.2651] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
360 Jasne AS, Chojecka P, Maran I, Mageid R, Eldokmak M, Zhang Q, Nystrom K, Vlieks K, Askenase M, Petersen N, Falcone GJ, Wira CR 3rd, Lleva P, Zeevi N, Narula R, Amin H, Navaratnam D, Loomis C, Hwang DY, Schindler J, Hebert R, Matouk C, Krumholz HM, Spudich S, Sheth KN, Sansing LH, Sharma R. Stroke Code Presentations, Interventions, and Outcomes Before and During the COVID-19 Pandemic. Stroke 2020;51:2664-73. [PMID: 32755347 DOI: 10.1161/STR.0000000000000347] [Cited by in Crossref: 40] [Cited by in F6Publishing: 17] [Article Influence: 20.0] [Reference Citation Analysis]
361 Hamad MK, Takruri DH, Patro SN, Habib MB, Verma V. Corpus callosum hematoma, as a rare complication of COVID-19. Clin Case Rep 2021;9:e05178. [PMID: 34938554 DOI: 10.1002/ccr3.5178] [Reference Citation Analysis]
362 Zaffina S, Lanteri P, Gilardi F, Garbarino S, Santoro A, Vinci MR, Carsetti R, Scorpecci A, Raponi M, Magnavita N, Camisa V. Recurrence, Reactivation, or Inflammatory Rebound of SARS-CoV-2 Infection With Acute Vestibular Symptoms: A Case Report and Revision of Literature. Front Hum Neurosci 2021;15:666468. [PMID: 34456694 DOI: 10.3389/fnhum.2021.666468] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
363 Liu JM, Tan BH, Wu S, Gui Y, Suo JL, Li YC. Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement, in the lethality of SARS-CoV-2 infection. J Med Virol 2021;93:1304-13. [PMID: 33002209 DOI: 10.1002/jmv.26570] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
364 Prasad K, Ahamad S, Gupta D, Kumar V. Targeting cathepsins: A potential link between COVID-19 and associated neurological manifestations. Heliyon 2021;7:e08089. [PMID: 34604555 DOI: 10.1016/j.heliyon.2021.e08089] [Reference Citation Analysis]
365 Lou JJ, Movassaghi M, Gordy D, Olson MG, Zhang T, Khurana MS, Chen Z, Perez-Rosendahl M, Thammachantha S, Singer EJ, Magaki SD, Vinters HV, Yong WH. Neuropathology of COVID-19 (neuro-COVID): clinicopathological update. Free Neuropathol 2021;2:2. [PMID: 33554218 DOI: 10.17879/freeneuropathology-2021-2993] [Cited by in F6Publishing: 10] [Reference Citation Analysis]
366 Qiu Q, Huang Y, Liu X, Huang F, Li X, Cui L, Luo H, Luo L. Potential Therapeutic Effect of Traditional Chinese Medicine on Coronavirus Disease 2019: A Review. Front Pharmacol 2020;11:570893. [PMID: 33343347 DOI: 10.3389/fphar.2020.570893] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
367 Evans N, Martinez E, Petrosillo N, Nichols J, Islam E, Pruitt K, Almodovar S. SARS-CoV-2 and Human Immunodeficiency Virus: Pathogen Pincer Attack. HIV AIDS (Auckl) 2021;13:361-75. [PMID: 33833585 DOI: 10.2147/HIV.S300055] [Reference Citation Analysis]
368 Wang F, Kream RM, Stefano GB. Long-Term Respiratory and Neurological Sequelae of COVID-19. Med Sci Monit 2020;26:e928996. [PMID: 33177481 DOI: 10.12659/MSM.928996] [Cited by in Crossref: 18] [Cited by in F6Publishing: 30] [Article Influence: 9.0] [Reference Citation Analysis]
369 Sisniega DC, Reynolds AS. Severe Neurologic Complications of SARS-CoV-2. Curr Treat Options Neurol 2021;23:14. [PMID: 33814894 DOI: 10.1007/s11940-021-00669-1] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, Karim AH, Sattar A. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front Neurol. 2020;11:518. [PMID: 32574248 DOI: 10.3389/fneur.2020.00518] [Cited by in Crossref: 66] [Cited by in F6Publishing: 62] [Article Influence: 33.0] [Reference Citation Analysis]
371 Morawiec N, Chyra D, Boroń A, Adamczyk B, Jaroszewicz J, Sobala-Szczygieł B, Adamczyk-Sowa M. Bilateral paralysis of peroneal nerve after COVID-19 disease: a case report. BMC Neurol 2022;22:91. [PMID: 35287619 DOI: 10.1186/s12883-022-02613-5] [Reference Citation Analysis]
372 Wei G, Gu J, Gu Z, Du C, Huang X, Xing H, Li L, Zhang A, Hu X, Huo J. Olfactory Dysfunction in Patients With Coronavirus Disease 2019: A Review. Front Neurol 2022;12:783249. [DOI: 10.3389/fneur.2021.783249] [Reference Citation Analysis]
373 Maramattom BV, Bhattacharjee S. Neurological Complications with COVID-19: A Contemporaneous Review. Ann Indian Acad Neurol 2020;23:468-76. [PMID: 33223662 DOI: 10.4103/aian.AIAN_596_20] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
374 van Eijk LE, Binkhorst M, Bourgonje AR, Offringa AK, Mulder DJ, Bos EM, Kolundzic N, Abdulle AE, van der Voort PH, Olde Rikkert MG, van der Hoeven JG, den Dunnen WF, Hillebrands JL, van Goor H. COVID-19: immunopathology, pathophysiological mechanisms, and treatment options. J Pathol 2021;254:307-31. [PMID: 33586189 DOI: 10.1002/path.5642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
375 Benito-Pascual B, Gegúndez JA, Díaz-Valle D, Arriola-Villalobos P, Carreño E, Culebras E, Rodríguez-Avial I, Benitez-Del-Castillo JM. Panuveitis and Optic Neuritis as a Possible Initial Presentation of the Novel Coronavirus Disease 2019 (COVID-19). Ocul Immunol Inflamm 2020;28:922-5. [PMID: 32870739 DOI: 10.1080/09273948.2020.1792512] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 12.5] [Reference Citation Analysis]
376 Leblanc JF, Germain M, Delage G, OʼBrien S, Drews SJ, Lewin A. Risk of transmission of severe acute respiratory syndrome coronavirus 2 by transfusion: A literature review. Transfusion 2020;60:3046-54. [PMID: 32798237 DOI: 10.1111/trf.16056] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
377 Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019: A Review. JAMA Neurol 2020;77:1018-27. [PMID: 32469387 DOI: 10.1001/jamaneurol.2020.2065] [Cited by in Crossref: 303] [Cited by in F6Publishing: 269] [Article Influence: 151.5] [Reference Citation Analysis]
378 Guerrero JI, Barragán LA, Martínez JD, Montoya JP, Peña A, Sobrino FE, Tovar-Spinoza Z, Ghotme KA. Central and peripheral nervous system involvement by COVID-19: a systematic review of the pathophysiology, clinical manifestations, neuropathology, neuroimaging, electrophysiology, and cerebrospinal fluid findings. BMC Infect Dis 2021;21:515. [PMID: 34078305 DOI: 10.1186/s12879-021-06185-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
379 Sachdev K, Agrawal S, Ish P, Gupta N, Raheja K. Neurological manifestations of COVID-19: A brief review. Indian J Med Res 2020;152:41-7. [PMID: 32859864 DOI: 10.4103/ijmr.IJMR_1395_20] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
380 Studart-neto A, Guedes BF, Tuma RDLE, Camelo Filho AE, Kubota GT, Iepsen BD, Moreira GP, Rodrigues JC, Ferrari MMH, Carra RB, Spera RR, Oku MHM, Terrim S, Lopes CCB, Passos Neto CEB, Fiorentino MD, De Souza JCC, Baima JPS, Da Silva TFF, Moreno CAM, Silva AMS, Heise CO, Mendonça RH, Fortini I, Smid J, Adoni T, Gonçalves MRR, Pereira SLA, Pinto LF, Gomes HR, Zanoteli E, Brucki SMD, Conforto AB, Castro LHM, Nitrini R. Neurological consultations and diagnoses in a large, dedicated COVID-19 university hospital. Arq Neuro-Psiquiatr 2020;78:494-500. [DOI: 10.1590/0004-282x20200089] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 9.0] [Reference Citation Analysis]
381 Bösel J. Critical care physicians treating COVID-19: mind the nervous system! Crit Care 2020;24:310. [PMID: 32513285 DOI: 10.1186/s13054-020-03026-x] [Reference Citation Analysis]
382 Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M, Bella R, Lanza G, Mansueto G. Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health 2021;18:1415. [PMID: 33546463 DOI: 10.3390/ijerph18041415] [Reference Citation Analysis]
383 de Figueiredo CS, Raony Í, Giestal-de-Araujo E. SARS-CoV-2 Targeting the Retina: Host-virus Interaction and Possible Mechanisms of Viral Tropism. Ocul Immunol Inflamm 2020;28:1301-4. [PMID: 32946292 DOI: 10.1080/09273948.2020.1799037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
384 Che Mohd Nassir CMN, Hashim S, Wong KK, Abdul Halim S, Idris NS, Jayabalan N, Guo D, Mustapha M. COVID-19 Infection and Circulating Microparticles-Reviewing Evidence as Microthrombogenic Risk Factor for Cerebral Small Vessel Disease. Mol Neurobiol 2021;58:4188-215. [PMID: 34176095 DOI: 10.1007/s12035-021-02457-z] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
385 Shehata GA, Lord KC, Grudzinski MC, Elsayed M, Abdelnaby R, Elshabrawy HA. Neurological Complications of COVID-19: Underlying Mechanisms and Management. Int J Mol Sci 2021;22:4081. [PMID: 33920904 DOI: 10.3390/ijms22084081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
386 Yassin A, Nawaiseh M, Shaban A, Alsherbini K, El-Salem K, Soudah O, Abu-Rub M. Neurological manifestations and complications of coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. BMC Neurol 2021;21:138. [PMID: 33784985 DOI: 10.1186/s12883-021-02161-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
387 Maruhashi T, Higashi Y. Pathophysiological Association of Endothelial Dysfunction with Fatal Outcome in COVID-19. Int J Mol Sci 2021;22:5131. [PMID: 34066226 DOI: 10.3390/ijms22105131] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
388 Verma K, Amitabh, Prasad DN, Kumar B, Kohli E. Brain and COVID-19 Crosstalk: Pathophysiological and Psychological Manifestations. ACS Chem Neurosci 2020;11:3194-203. [PMID: 33006881 DOI: 10.1021/acschemneuro.0c00446] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
389 Delcuve GP, Lakowski TM, Su RC, Beacon TH, Davie JR. SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities. IUBMB Life 2020;72:2313-30. [PMID: 32918855 DOI: 10.1002/iub.2380] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
390 Donina ZA. Causes of Hypoxemia in COVID-19. J Evol Biochem Phys 2022;58:73-80. [DOI: 10.1134/s0022093022010070] [Reference Citation Analysis]
391 Robles LA. Bilateral Large Vessel Occlusion Causing Massive Ischemic Stroke in a COVID-19 Patient. J Stroke Cerebrovasc Dis 2021;30:105609. [PMID: 33429238 DOI: 10.1016/j.jstrokecerebrovasdis.2021.105609] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
392 Gonçalves de Andrade E, Šimončičová E, Carrier M, Vecchiarelli HA, Robert MÈ, Tremblay MÈ. Microglia Fighting for Neurological and Mental Health: On the Central Nervous System Frontline of COVID-19 Pandemic. Front Cell Neurosci 2021;15:647378. [PMID: 33737867 DOI: 10.3389/fncel.2021.647378] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
393 Edlow BL, Claassen J, Victor JD, Brown EN, Schiff ND. Delayed reemergence of consciousness in survivors of severe COVID-19. Neurocrit Care 2020;33:627-9. [PMID: 33174149 DOI: 10.1007/s12028-020-01133-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
394 Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.Signal Transduct Target Ther. 2020;5:293. [PMID: 33361764 DOI: 10.1038/s41392-020-00454-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 27.5] [Reference Citation Analysis]
395 Tan BH, Liu JM, Gui Y, Wu S, Suo JL, Li YC. Neurological involvement in the respiratory manifestations of COVID-19 patients. Aging (Albany NY) 2021;13:4713-30. [PMID: 33582654 DOI: 10.18632/aging.202665] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Kaiser K, Bryja V. Choroid Plexus: The Orchestrator of Long-Range Signalling Within the CNS. Int J Mol Sci 2020;21:E4760. [PMID: 32635478 DOI: 10.3390/ijms21134760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
397 Chakravarty N, Senthilnathan T, Paiola S, Gyani P, Castillo Cario S, Urena E, Jeysankar A, Jeysankar P, Ignatius Irudayam J, Natesan Subramanian S, Lavretsky H, Joshi S, Garcia G Jr, Ramaiah A, Arumugaswami V. Neurological pathophysiology of SARS-CoV-2 and pandemic potential RNA viruses: a comparative analysis. FEBS Lett 2021. [PMID: 34757622 DOI: 10.1002/1873-3468.14227] [Reference Citation Analysis]
398 Mainali S, Darsie ME. Neurologic and Neuroscientific Evidence in Aged COVID-19 Patients. Front Aging Neurosci 2021;13:648662. [PMID: 33833676 DOI: 10.3389/fnagi.2021.648662] [Reference Citation Analysis]
399 Lionetti V, Bollini S, Coppini R, Gerbino A, Ghigo A, Iaccarino G, Madonna R, Mangiacapra F, Miragoli M, Moccia F, Munaron L, Pagliaro P, Parenti A, Pasqua T, Penna C, Quaini F, Rocca C, Samaja M, Sartiani L, Soda T, Tocchetti CG, Angelone T. Understanding the heart-brain axis response in COVID-19 patients: A suggestive perspective for therapeutic development. Pharmacol Res 2021;168:105581. [PMID: 33781873 DOI: 10.1016/j.phrs.2021.105581] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
400 Kaundal RK, Kalvala AK, Kumar A. Neurological Implications of COVID-19: Role of Redox Imbalance and Mitochondrial Dysfunction. Mol Neurobiol 2021. [PMID: 34110602 DOI: 10.1007/s12035-021-02412-y] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
401 Romero A, Ramos E, López-Muñoz F, Gil-Martín E, Escames G, Reiter RJ. Coronavirus Disease 2019 (COVID-19) and Its Neuroinvasive Capacity: Is It Time for Melatonin? Cell Mol Neurobiol 2020. [PMID: 32772307 DOI: 10.1007/s10571-020-00938-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
402 Conte C. Possible Link between SARS-CoV-2 Infection and Parkinson's Disease: The Role of Toll-Like Receptor 4. Int J Mol Sci 2021;22:7135. [PMID: 34281186 DOI: 10.3390/ijms22137135] [Reference Citation Analysis]
403 Schulte EC, Hauer L, Kunz AB, Sellner J. Systematic review of cases of acute myelitis in individuals with COVID-19. Eur J Neurol 2021. [PMID: 34060708 DOI: 10.1111/ene.14952] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
404 Bernard I, Limonta D, Mahal LK, Hobman TC. Endothelium Infection and Dysregulation by SARS-CoV-2: Evidence and Caveats in COVID-19. Viruses 2020;13:E29. [PMID: 33375371 DOI: 10.3390/v13010029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 11.5] [Reference Citation Analysis]
405 Jakhmola S, Indari O, Chatterjee S, Jha HC. SARS-CoV-2, an Underestimated Pathogen of the Nervous System. SN Compr Clin Med 2020;:1-10. [PMID: 33015550 DOI: 10.1007/s42399-020-00522-7] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
406 Pennisi M, Lanza G, Falzone L, Fisicaro F, Ferri R, Bella R. SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms. Int J Mol Sci 2020;21:E5475. [PMID: 32751841 DOI: 10.3390/ijms21155475] [Reference Citation Analysis]
407 Tang X, Zheng F. A review of ischemic stroke in COVID-19: currently known pathophysiological mechanisms. Neurol Sci 2021. [PMID: 34671854 DOI: 10.1007/s10072-021-05679-0] [Reference Citation Analysis]
408 Malik P, Patel K, Akrmah M, Donthi D, Patel U, Khader SN, Asiry S. COVID-19: a Disease with a Potpourri of Histopathologic Findings-a Literature Review and Comparison to the Closely Related SARS and MERS. SN Compr Clin Med 2021;:1-28. [PMID: 34396046 DOI: 10.1007/s42399-021-01029-5] [Reference Citation Analysis]
409 Frisoni P, Neri M, D'Errico S, Alfieri L, Bonuccelli D, Cingolani M, Di Paolo M, Gaudio RM, Lestani M, Marti M, Martelloni M, Moreschi C, Santurro A, Scopetti M, Turriziani O, Zanon M, Scendoni R, Frati P, Fineschi V. Cytokine storm and histopathological findings in 60 cases of COVID-19-related death: from viral load research to immunohistochemical quantification of major players IL-1β, IL-6, IL-15 and TNF-α. Forensic Sci Med Pathol 2021. [PMID: 34463916 DOI: 10.1007/s12024-021-00414-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
410 Lewis A, Frontera J, Placantonakis DG, Lighter J, Galetta S, Balcer L, Melmed KR. Cerebrospinal fluid in COVID-19: A systematic review of the literature. J Neurol Sci 2021;421:117316. [PMID: 33561753 DOI: 10.1016/j.jns.2021.117316] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 15.0] [Reference Citation Analysis]
411 Oh TK, Park HY, Song I. Risk of psychological sequelae among coronavirus disease‐2019 survivors: A nationwide cohort study in South Korea. Depression and Anxiety 2021;38:247-54. [DOI: 10.1002/da.23124] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
412 Anand H, Ende V, Singh G, Qureshi I, Duong TQ, Mehler MF. Nervous System-Systemic Crosstalk in SARS-CoV-2/COVID-19: A Unique Dyshomeostasis Syndrome. Front Neurosci 2021;15:727060. [PMID: 34512253 DOI: 10.3389/fnins.2021.727060] [Reference Citation Analysis]
413 Stein LK, Mayman NA, Dhamoon MS, Fifi JT. The emerging association between COVID-19 and acute stroke. Trends Neurosci 2021;44:527-37. [PMID: 33879319 DOI: 10.1016/j.tins.2021.03.005] [Reference Citation Analysis]
414 Murta V, Villarreal A, Ramos AJ. Severe Acute Respiratory Syndrome Coronavirus 2 Impact on the Central Nervous System: Are Astrocytes and Microglia Main Players or Merely Bystanders? ASN Neuro 2020;12:1759091420954960. [PMID: 32878468 DOI: 10.1177/1759091420954960] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 7.5] [Reference Citation Analysis]
415 Maiese A, Manetti AC, La Russa R, Di Paolo M, Turillazzi E, Frati P, Fineschi V. Autopsy findings in COVID-19-related deaths: a literature review. Forensic Sci Med Pathol. 2020;. [PMID: 33026628 DOI: 10.1007/s12024-020-00310-8] [Cited by in Crossref: 43] [Cited by in F6Publishing: 52] [Article Influence: 21.5] [Reference Citation Analysis]
416 Battagello DS, Dragunas G, Klein MO, Ayub ALP, Velloso FJ, Correa RG. Unpuzzling COVID-19: tissue-related signaling pathways associated with SARS-CoV-2 infection and transmission. Clin Sci (Lond) 2020;134:2137-60. [PMID: 32820801 DOI: 10.1042/CS20200904] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 12.5] [Reference Citation Analysis]
417 De Michele M, Kahan J, Berto I, Schiavo OG, Iacobucci M, Toni D, Merkler AE. Cerebrovascular Complications of COVID-19 and COVID-19 Vaccination. Circ Res 2022;130:1187-203. [PMID: 35420916 DOI: 10.1161/CIRCRESAHA.122.319954] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
418 Kumar D, Jahan S, Khan A, Siddiqui AJ, Redhu NS, Wahajuddin, Khan J, Banwas S, Alshehri B, Alaidarous M. Neurological Manifestation of SARS-CoV-2 Induced Inflammation and Possible Therapeutic Strategies Against COVID-19. Mol Neurobiol 2021;58:3417-34. [PMID: 33715108 DOI: 10.1007/s12035-021-02318-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
419 Hosseini N, Nadjafi S, Ashtary B. Overview of COVID-19 and neurological complications. Rev Neurosci 2021;32:671-91. [PMID: 33583157 DOI: 10.1515/revneuro-2020-0116] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
420 Al-Kuraishy HM, Al-Gareeb AI, Qusti S, Alshammari EM, Gyebi GA, Batiha GE. Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm. ASN Neuro 2021;13:17590914211057635. [PMID: 34755562 DOI: 10.1177/17590914211057635] [Reference Citation Analysis]
421 Silva MTT, Lima M, Araujo AQ. SARS-CoV-2: Should We Be Concerned about the Nervous System? Am J Trop Med Hyg 2020;103:993-8. [PMID: 32682454 DOI: 10.4269/ajtmh.20-0447] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
422 Dey J, Alam MT, Chandra S, Gupta J, Ray U, Srivastava AK, Tripathi PP. Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of the respiratory center of the brain. J Med Virol 2021;93:1296-303. [PMID: 32964419 DOI: 10.1002/jmv.26521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
423 Johansson A, Mohamed MS, Moulin TC, Schiöth HB. Neurological manifestations of COVID-19: A comprehensive literature review and discussion of mechanisms. J Neuroimmunol 2021;358:577658. [PMID: 34304141 DOI: 10.1016/j.jneuroim.2021.577658] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
424 Ram A, Jeelani H, Kumar D, Patel H. Generalised myoclonus associated with COVID-19 infection. BMJ Case Rep 2021;14:e243780. [PMID: 34301706 DOI: 10.1136/bcr-2021-243780] [Reference Citation Analysis]
425 Ellul M, Benjamin L, Singh B, Lant S, Michael B, Kneen R, Defres S, Sejvar J, Solomon T. Neurological Associations of COVID-19. SSRN Journal. [DOI: 10.2139/ssrn.3589350] [Cited by in Crossref: 33] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
426 Cetinkaya T, Kurt MM, Akpolat C. Assessment of Retinal Neurodegeneration and Choroidal Thickness in COVID-19 Patients Using Swept-Source OCT Technology. Klin Monbl Augenheilkd 2021. [PMID: 33853186 DOI: 10.1055/a-1340-0066] [Reference Citation Analysis]
427 Hassett CE, Frontera JA. Neurologic aspects of coronavirus disease of 2019 infection. Curr Opin Infect Dis 2021;34:217-27. [PMID: 33769966 DOI: 10.1097/QCO.0000000000000731] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
428 Rosato C, Bolondi G, Russo E, Oliva A, Scognamiglio G, Mambelli E, Longoni M, Rossi G, Agnoletti V. Clinical, electromyographical, histopathological characteristics of COVID-19 related rhabdomyolysis. SAGE Open Med Case Rep 2020;8:2050313X20983132. [PMID: 33489234 DOI: 10.1177/2050313X20983132] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
429 Baig AM. Covert Pathways to the Cranial Cavity: Could These Be Potential Routes of SARS-CoV-2 to the Brain? ACS Chem Neurosci 2020;11:3185-7. [PMID: 33030333 DOI: 10.1021/acschemneuro.0c00604] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
430 Negri S, Faris P, Moccia F. Endolysosomal Ca2+ signaling in cardiovascular health and disease. Int Rev Cell Mol Biol 2021;363:203-69. [PMID: 34392930 DOI: 10.1016/bs.ircmb.2021.03.001] [Reference Citation Analysis]